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ABSTRACT 
Produced water is a complex mixture discharged to sea in high volumes containing 
compounds at low concentrations. Compounds in mixtures can modify each other’s expected 
toxic effect predicted from single exposure, and to obtain information about potential 
interactions is important. Carbazole is present in produced water and is suggested to 
contribute to produced waters potential of modifying cytochrome P450 (CYP) activity. 
Information on toxic effect of carbazole in relation to produced water is limited. Carbazole is 
included in this project to study its potential for modifying CYP 1A activity singly and in 
mixtures. The aromatic and phenolic fractions of produced water are significant contributors 
to toxicity and concentration of organic compounds in produced water. As representative 
compounds of these fractions, benzo(a)pyrene (BaP) and 2,5-dimethylphenol (DMP) are 
included in this master project.  
 
Biotransformation of harmful compounds is often initiated by CYPs catalysing oxidation 
reactions. Modified CYP 1A protein or activity is an indication of interaction between a 
compound and the biological system. Biotransformation catalysed by CYP 1A can produce 
reactive oxygen species (ROS) and reactive metabolites. Increased contaminant load can 
deplete reduced glutathione (GSH) through increase in conjugation reactions. In addition to 
being an important conjugate, GSH is also an important antioxidant. With potential both to 
increase extent of DNA damage by increasing levels of ROS and producing reactive 
metabolites, and interfere with glutathione dependent defence protecting against oxidative 
stress, compounds interacting with CYP 1A and conjugation enzymes are suggested to 
contribute to DNA damage.  
 
The aims of this master project were to determine carbazoles potential for modifying CYP 1A 
activity measured as ethoxyresorufin-O-deethylase (EROD) activity, to evaluate interaction in 
ternary mixtures with carbazole and two compounds representing fractions contributing to 
toxicity of produced water, and also to study correlation between biotransformation activity 
and genotoxicity by measuring DNA double strand breaks (DSB).  
 
The aims were achieved by studying single compounds and ternary mixture in vitro in the 
continuous cell line PLHC-1. Concentrations of the three compounds in the ternary mixtures 
were varied using a statistical design. Results were analysed using partial least squares 
projection to latent structures (PLS). Concentrations of the compounds included in the design 
were determined from cytotoxicity results, EROD concentration effect curves for single 
compounds and concentrations measured in the marine environment.  
 
It was hypothesized that compounds will modify EROD activity in PLHC-1 differently when 
present in ternary mixtures compared to single exposure. It was further suggested that ternary 
mixtures inducing high EROD activity also will enhance formation of DNA DSB in PLHC-1 
cells. Carbazole was suggested to modify EROD activity induced by the other compounds.   
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Exposure of PLHC-1 to BaP singly significant induced EROD activity. Carbazole induced 
EROD activity slightly, and significant for the highest concentration in one replicate. An 
overall non-significant decrease in EROD activity was seen in PLHC-1 exposed to DMP. 
Exposure of PLHC-1 to ternary mixtures resulted in significant and positive PLS regression 
coefficient for both BaP and carbazole. The crossed term carbazole×DMP decreased EROD 
activity significantly. Squared terms for all three compounds were significant, equal and 
negative. 
 
The results indicate that potential of carbazole at inducting CYP 1A is different alone 
compared to when it is present in mixture. Carbazole is suggested to contribute to EROD 
inducing potency in the ternary mixtures. Effect of carbazole on EROD activity is indicated to 
be dependent on co-exposed compounds. How EROD activity is modulated when exposed to 
DMP is suggested to be dependent on exposure conditions. The significant substantial square 
terms indicate that all three compounds interact with catalytic EROD activity at higher 
concentrations.  
 
Catalytic EROD activity is presumed to be a good indication of potential interaction between 
compounds and biological systems. Determining extent of DNA damage by electrophoretic 
separation of DNA did not give consistent result. Electrophoretic separation of DNA from 
PLHC-1 is assumed to be more pertinent for determining genotoxicity of certain metals in 
PLHC-1. Statistical design and projection techniques are considered valuable tools when 
assessing toxicity of mixtures.   
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OPPSUMMERING 
Produsert vann er en kompleks blanding som inneholder lave konsentrasjoner av mange 
forbindelser. Dette vandige avfallet fra oljeproduksjon slippes ut i det marine miljø i høye 
volum. Når forbindelser foreligger i blanding kan de ha en annen toksisk effekt enn de har 
alene. Det er derfor viktig å ha kunnskap om potentielle interaksjoner. Carbazol er tilstede i 
produsert vann og er foreslått som en av forbindelsene i produsert vann som har potensial for 
å endre cytokrom P450 (CYP) 1A aktivitet. Informasjon om toksiske effekter av carbazol i 
forbindelse med ekspoenering for produsert vann er begrenset. Carbazol er inkludert i denne 
masteroppgaven for å studere dens potensial for å modifisere CYP 1A aktivitet alene og som 
komponent i blanding. Fenol og aromatisk fraksjon er viktige bidragsytere til toksisitet. For å 
representere disse fraksjonen er benso(a)pyren (BaP) og 2,5-dimetylfenol (DMP) inkludert i 
studiet. Fenoler med kort hydrokarbon kjede er mest utbredt i produsert vann.  
 
Biotransformasjon av skadelige forbindelser begynner ofte med en oksidativ reaksjon 
katalysert av CYP enzymer. Modifisert CYP 1A protein eller aktivitet er en indikasjon på 
interaksjon mellom forbindelser og et biologisk system. Biotransformasjon katalysert av CYP 
1A kan produsere reaktive oksygen forbindelser (ROS) og reaktive metabolitter. Økt 
belastning for forurensende stoffer kan utarme redusert glutathion (GSH) gjennom økt bruk i 
konjugerinsreaksjoner. I tillegg til å være vikig i konjugeringsreaksjoner er GSH også en 
viktig antioksidant. Med potensial for å øke mengde skade på DNA ved økt oksidativt stress 
og å resultere i reaktive metabolitter, og ved samtidig å ha potensial til å forstyrre cellulært 
forsvar mot oksidativt stress kan forbindelser som interagerer med CYP 1A og 
konjugeringsreaksjoner bidra til økt forekomst av DNA skade.  
 
Hensikten med dette masterprosjektet var å evaluere carbazols potensial for å påvirke CYP 
1A aktivitet målt som ethoxyresorufin-O-deethylase (EROD) aktivitet, å evaluere interaksjon 
i tertiære blandinger med carbazol og to forbindelser som representerer fraksjoner som bidrar 
til toksisitet av produsert vann, og også å se på korrelasjon mellom biotransformasjon og 
gentoksistet målt som DNA-dobbelttrådbrudd (DNA DSB).  
 
Dette ble gjort ved å studere forbindelser alene og i tertiære blaninger in vitro i den 
kontinuerlige cellelinja PLHC-1. Et statitisk forsøksdesign ble brukt for å bestemme 
konsentrasjonsmatrisen for de tertiære forbindelsene. Resultatene ble analysert med 
projeksjon til latente strukturer ved minste kvadraters metode (PLS). Konsentrasjon av 
forbindelsene inkludert i designet ble bestemt ved å se på cytotoksisitet og EROD 
konsentrasjons effekt kurver for enkle forbindelser. Målte konsentrasjoner i naturmiljøet ble 
også vurdert.  
 
Det ble hypotetisert at forbindelser ville ha ulik effekt på EROD aktivitet avhengiga av om 
ekspoenringen skjedde i blanding eller ikke. Videre ble det foreslått at blandinger som 
induserer høyere EROD aktivitet ville resultere i høyere forekomst av DNA DSB. Carbazol 
ble foreslått å modifisere EROD aktivitet indusert av de andre forbindelsene.  
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Resultater viser at BaP induserte EROD aktivitet signifikant alene. Carbazol induserte EROD 
aktivitet i liten grad, men var signifikant for den høyeste konsentrasjonen i et replikat. En 
generell ikke-signifikant reduksjon i EROD aktivitet ble sett i PLHC-1 eksponert for DMP. 
Analyse av resultatene fra eksponering av PLHC-1 for tertiære blandinger med PLS regresjon 
ga positive signifikante PLS regresjonskoeffisienter for BaP og carbazol. Et interaksjonsledd, 
DMP×Carbazol, var signifikant negativ. Kvadratiske ledd for alle tre forbindelsene var 
signifikante, like og negative.  
 
Resultatene indikerer at forbindelsene har ulik effekt når den er tilstede alene sammenlignet 
med blanding. Det antydes ut fra resultatene at carbazol kan ha potensial for å indusere EROD 
aktivitet når den er tilsted i tertiære blandinger. Effekt av carbazol på EROD aktivitet er 
indikert å være avhengig av andre forbindelser i blandingen. Hvordan EROD aktivitet 
moduleres etter eksponering for DMP antydes å være avhengig av eksponeringsforhold. De 
signifikante negative kvadratiske leddene sett for alle tre forbindelene tyder på at alle tre 
forbindelser interagerer med katalytisk EROD aktivitet ved høyere konsentrasjoner.  
 
Katalytisk EROD aktivitet er antatt å være en god indikasjon på potensiell effekt av 
forbindelser i biologiske system. Elektroforetisk separasjon av DNA for å bestemme omfang 
av DNA skade ga ikke tilfredstillende resultat. Metoden antas å være bedre egnet for å 
bestemme genotoksisk potensial av metaller i PLHC-1. Statistisk design og PLS framtår som 
verdifulle verktøy for å evaluere toksisitet for blandinger.   
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ABRIVIATIONS 
AhR Aryl hydrocarbon receptor 
ANOVA Analysis of variance 
ARNT Aryl hydrocarbon nuclear translocator 
APs Alkyl phenols 
BaP Benzo(a)pyrene 
BSA Bovine serum albumin 
BTEXs Benzene Toluene Ethylbenzene Xylene 
CAT Catalase 
CYP Cytochrome P450 
DNA Deoxyribonucleic acid 
DMP 2,5-dimethylphenol 
DSB Double strand break 
EC50 Median effective concentration 
ELISA Enzyme linked immunosorbent assay 
ER 7-Ethoxyresorufin 
EROD  Ethoxyresorufin-O-deethylase 
GNMT Glycine-N-methyltransferase 
GSH Reduced glutathione  
GST Glutathione transferase 
GSSG Oxidized glutathione 
GPx Glutathione peroxidase 
GR Glutathione reductase 
H2O2 Hydrogen peroxide 
HR Homologous recombination 
Kow  Octanol/water partition coefficient 
Lmax Maximal molecular length 
LMPA Low melting point agarose 
LV Latent variables 
MLR Multiple linear regression 
MML Median molecular length 
NADPH Nicotinamide adenine dinucleotide phosphate 
NER Nucleotide excision repair 
NPDs Naphtalene Phenanthrene and Dibenzothiophene 
NSO-HET Heterocycylic compounds containing nitrogen, sulphur or oxygen 
O2 Molecular oxygen 
O2
-
 Superoxid radical 
PAH Polycyclic aromatic hydrocarbons 
PAS PER ARNT SIM 
PCA Principal components analysis 
PCB Polychlorinated biphenyl 
PLHC-1 Poeciliopsis lucida hepatocellular carcinoma 
PLS Projection to latent structure by partial least squares 
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Q
2
 Predicted variance 
R
2
 Explained variance 
Rf Relative front 
RNSB/kb Relative number of strand breaks per kilo base 
ROS Reactive oxygen species 
RSD%  Per cent relative standard deviation 
RTG-2 Rainbow trout gonadal cell line 
SS Total sum of squares  
SSregr Sum of squares for regression model 
SSresid Sum of squares for residuals 
SSlof Sum of squares of lack of fit 
SSpe Sum of squares of pure experimental error 
TCDD Tetrachlorodibenzodioxin 
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1 INTRODUCTION 
1.1 Discharges to sea from oil production 
The largest discharge to sea from oil production is of water with dispersed oil. This water is 
called produced water. Oil reservoirs contain varying amounts of water (OLF, 2010). 
Produced water is separated from the oil, processed and discharged to sea or injected back 
into reservoirs (Utvik, 1999). Permitted amount of dispersed oil in produced water discharged 
to sea at the Norwegian continental shelf is 30 mg/L (OLF, 2010). Figure 1 presents volumes 
of produced water discharged to sea and volumes injected back into reservoirs from 1999 to 
2009. 
 
 
 
Figure 1.1. Volumes of produced water discharged to sea (light blue) and volumes of produced water 
injected back into reservoirs (dark blue) from 1999 to 2009 at the Norwegian Continental shelf (OLF, 
2010).  
 
 
1.2 Produced water is a complex mixture 
Produced water is discharged to sea in high volumes and contains low amounts of dispersed 
oil and dissolved substances (OLF, 2010). Volumes of produced water are expected to 
increase as reservoirs get older (Thomas et al., 2004). Composition of produced water is field 
specific and complex (Utvik, 1999).  
 
Compounds present in produced water include dispersed oil, dissolved hydrocarbons, organic 
acids, phenols, metals, and traces of chemicals added during extraction and production of oil. 
Dissolved hydrocarbons are dominated by the volatile aromatic fraction of the oil, by 
benzene, toluene, ethyl benzene and xylene (the BTEX compounds). Polycyclic compounds 
are dominated by naphthalene, phenanthrene and dibenzohiophenes (the NPDs) and their C1-
C3 alkyl homologues. High molecular weight polycyclic aromatic hydrocarbons (PAHs) like 
benzo(a)pyrene (BaP) are present. Phenols are usually alkylated up to C7. Concentration of 
alkylated homologues of both the NPDs and phenols decreases with increasing alkylation 
1 Introduction 
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(Utvik, 1999). Environmental exposure to produced water is assumed to be fluctuating and 
low (Holth et al., 2008). 
 
Produced water is a complex mixture (Utvik, 1999). Complex mixtures consist of numerous 
compounds and are not well characterized, neither quantitatively nor qualitatively, while 
simple mixtures have known composition and the total number of compounds present is ten or 
fewer (Groten, 2000). Components in mixtures can influence each other’s toxicity (Cassee et 
al., 1998). Combined action of compounds in mixtures is discussed in Chapter 1.7. 
 
 
1.3 Compounds present in produced water  
Main contributors to toxicity of produced water are aromatic and phenolic fractions (Johnsen 
et al., 1994). In this project one representative compound for each of the two groups will be 
included in a simple mixture together with carbazole, for analyses of combined action. 
 
1.3.1 Alkyl phenols 
Present in oil, alkyl phenols (APs) distribute into the water phase of oil-water-systems 
(Bennett et al., 2007). General structure of APs is presented in Figure 1.2, together with 
structure of 2,5-dimethylphenol (DMP). The hydrocarbon chain of APs varies in length, 
degree of branching and position on the phenol ring (Solomons and Fryhle, 2004). 
Concentration of short-chain APs differ more between reservoirs than concentration of long-
chain APs (Boitsov et al., 2007).  
 
OH
n
OH
 
 
Figure 1.2. The general structure of alkyl phenol (left) and the structure of 2,5-dimethylphenol (right) 
(DMP). 
 
Toxic effects seen after exposure to APs are likely chronic, since acute toxicity of APs is 
considered to be low (Boitsov et al., 2004). Toxicity of APs is dependent on molecular 
structure and degree of alkylation, generally increasing with increasing degree of alkylation 
(Jonsson et al., 2008). Long-chain APs have received attention because of their demonstrated 
potential to act as oestrogen mimics in vitro (Routledge and Sumpter, 1997) and in vivo 
(Nimrod and Benson, 1996; Arukwe et al., 2000; Arukwe et al., 2001). The C6-C8 para 
substituted tertiary APs are known as the most potent oestrogen mimics, but C3-C5 APs also 
show low oestrogenic activity. Phenol and C1-C3 APs constitute 95% of total AP 
concentration in produced water (Jonsson et al., 2008). Potential oestrogenic activity of 
produced water is assumed not to be caused by these APs, since ortho-substituted and short-
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chain APs have little or no oestrogenic activity (Routledge and Sumpter, 1997; Thomas et al., 
2004).  
 
Exposure of two year old cod to a mixture of C4 to C7 APs at low concentrations changed 
levels of gene transcripts involved in xenobiotic biotransformation, oxidative stress defence, 
glucose metabolism and apoptosis. Gene transcripts encoding cytochrome P450 1A (CYP 1A) 
and sulfotransferase (SULT2) were up regulated. Gene transcripts encoding glutathione 
transferase (GSTs) were down regulated, while glutathione peroxidase transcripts (GPx4) 
were up regulated (Lie et al., 2009). Concomitant exposure of juvenile Atlantic cod to crude 
oil and a C2 to C5 AP mixture produced decreased CYP 1A protein expression and non-
significant increased ethoxyresorufin-O-deethylase (EROD) activity compared to control 
individuals (Sturve et al., 2006). Exposure of first spawning cod to a C4 to C7 AP mixture 
resulted in a dose dependent increase in CYP 1A protein in male Atlantic cod after one and 
four weeks exposure to a mixture of C4 to C7 APs. No change was seen in CYP 1A activity. 
Exposure of female fish produced higher EROD activity and no change in CYP 1A protein.  
In vitro studies with pooled microsomes from fish treated with a potent inducer of CYP 1A 
activity showed efficient inhibition of induced activity (Hasselberg et al., 2004b). Combined 
exposure of cod to oil and a C2 to C5 AP mixture modulated oxidative stress parameters 
manifested as elevated levels of glutathione reductase (GR) and catalase (CAT), and an 
increase in per cent oxidized glutathione (GSSG) (Sturve et al., 2006). Modulation of total 
glutathione (GSH) levels and GR activity levels by C4 to C7 AP mixture observed in Atlantic 
cod was suggested to increase oxidative stress (Hasselberg et al., 2004a). 
 
Decreased CYP 1A concentration or activity after exposure to APs can alter 
biotransformation of other xenobiotics and impair the cells ability to detoxify and excrete 
other compounds. Altered GSH status can increase cells susceptibility towards reactive 
oxygen species (ROS) (Sturve et al., 2006).  
 
1.3.2 Carbazole 
Carbazole and its alkyl and benzene derivatives are the main neutral nitrogen containing 
compounds in crude oil (Frolov et al., 1989). Structure of 9H-carbazole is shown in Fig. 1.4. 
Carbazole is present in produced water and is suggested to contribute to CYP 1A inducing 
potential of produced water (Ståle Johnsen, pers. comm.) 
 
 
Figure 1.3. Structure of 9H-carbazole. 
 
Combined effect assessment, fractionation procedures and chemical characterization have 
identified heterocyclic polycyclic compounds as potent inducers of CYP 1A activity (Brack 
 N
 H
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and Schirmer, 2003). Heterocyclic compounds containing nitrogen, sulphur or oxygen (NSO-
HET) are expected to have similar affinities for the aryl hydrocarbon receptor (AhR) and 
similar CYP 1A inducing potencies as structurally similar PAHs (Jung et al., 2001). 
Azaarenes and NPAHs are shown to induce CYP 1A protein and activity. Potency of inducing 
CYP 1A activity expressed as –log EC50 correlated with the logarithm of the octanol water 
partition coefficient log Kow and maximal molecular length of the compound (Lmax) (Jung et 
al., 2001). Different AhR binding affinities for nitrated heterocyclic compounds can be 
explained by different net polarizability affected by position of nitration (Lofroth et al., 1984). 
Nitrated derivatives of BaP have higher affinities for AhR compared to BaP in affinity studies 
with rat (Lofroth et al., 1984). 
 
Recently, carbazole has been reported to activate AhR in the DR-CALUX assay with the 
pGudLuc1.1 transfected rat hepatoma cell line H4IIE. Modulation of EROD activity was not 
observed (Hinger et al., 2011). Exposure of killifish to carbazole singly increased EROD 
activity twofold compared to control. When present in mixed exposure, carbazole inhibited 
EROD activity induced by a potent inducer. Half maximum inhibiting concentration (IC50) 
was 4.6 × 10
-3
 mg/mL (Wassenberg et al., 2005). 
 
Mechanism of induction of EROD activity by nitrated heterocyclic compounds, and also for 
some PAHs, is complex and is, as far as is known, not yet fully elucidated. Some compounds 
show poor correlation between AhR binding affinity and EROD inducing potency (Piskorska-
Pliszczynska et al., 1986; Hinger et al., 2011).  
 
1.3.3 Polycyclic aromatic hydrocarbons  
Aromatic hydrocarbons have delocalized electrons in a six carbon ring system (Solomons and 
Fryhle, 2004). Compounds with two or more fused benzene rings are called PAHs (Staal et 
al., 2007). They are ubiquitous in the environment (Srogi, 2007) and constituents of crude oil 
(Monteiro et al., 2000). Presence of PAHs in marine environments can be due to both 
pyrogenic and petrogenic sources (Oliveira et al., 2009). Oil production at the Norwegian 
continental shelf results in discharges of both types (OLF, 2010). Petrogenic PAHs are 
presented in Figure 1.3. 
 
 
 
Figure 1.4. Structure of phenanthene (left) and naphthalene (right). Structure of BaP is presented in Fig. 1.5.   
 
A concentration gradient of PAHs has been measured towards oil production facilities (Utvik, 
1999). Accumulation of PAHs in sediments is seen, caused by resistance towards biological 
degradation and persistence in the environment (Oliveira et al., 2009).  
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There are numerous biological effects of PAHs, which include among others elevated levels 
of CYP 1A (Hylland et al., 2006), genotoxicity (Aas et al., 2000), deoxyribonucleic acid 
(DNA) adduct formation (Beyer et al., 2001), impairment of reproduction (Monteiro et al., 
2000), altered antioxidant status (Sturve et al., 2006), and increased activity of GST (Hylland 
et al., 2006). Incorrect repair of PAH-DNA adducts can result in mutations (Staal et al., 2007). 
 
Adverse effects of PAHs may be mediated via the AhR pathway (Hahn, 1998), which is 
responsive to planar aromatic compounds (Okey et al., 1994). Gene products regulated by 
AhR include CYPs, GST, glucuronosyl transferase and quinone oxireductase (Di Giulio and 
Newman, 2007). By altering levels of CYPs and conjugation enzymes PAHs can potentially 
interfere with endogenous processes (Monteiro et al., 2000). Low molecular weights PAHs 
are suggested to mediate toxicity independent of the AhR pathway (Incardona et al., 2005). 
 
1.4 Bioavailability  
Compounds discharged to the environment are subject to environmental processes, which 
together with emission patterns and physiochemical properties of the compounds determine 
distribution and concentration in biota (van der Oost et al., 2003). Water solubility and 
susceptibility to degradation largely determines fate of APs after discharge to sea. In the 
environment, APs have high mobility due to solubility in both polar and non-polar systems. 
Compounds with longer hydrocarbon chains have lower water solubility and are degraded 
more slowly (Boitsov et al., 2004). Low molecular PAHs are the most bioavailable PAHs 
(Holth et al., 2008). Increased mobility and bioavailability are expected for NSO-HETs 
compared to analogous PAHs (Hinger et al., 2011).  
 
Important for exposure of marine organisms at lower trophic levels is the water soluble 
fraction of PAHs (Utvik and Johnsen, 1999). Uptake of PAHs to fish can be direct from water 
and via diet (Grung et al., 2009). Direct uptake of compounds from water is called 
bioconcentration while uptake of compounds from food is called biomagnification (van der 
Oost et al., 2003). Bioconcentration of APs increases with the length of the hydrocarbon chain 
(Mcleese et al., 1981) and is efficient for compounds with log Kow below five (Sundt et al., 
2009). It is necessary to establish a correlation between external exposure, internal dose and 
adverse effects for suspected harmful compounds present in the environment (van der Oost et 
al., 2003). 
 
Close contact between water and blood over the gill epithelial membrane  provide efficient 
uptake of water soluble compounds to fish (Castaño et al., 2003). Lipid soluble compounds 
can biomagnify and be found at high concentrations at higher ecosystem levels. 
Biomagnification is considered more important for total contaminant burden in large fish (van 
der Oost et al., 2003). Compounds with log Kow between 5 and 8 are suggested to biomagnify 
in aquatic food webs (Kelly et al., 2007). 
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Fish have efficient metabolism and readily excrete short-chain APs (Sundt et al., 2009) and 
PAHs. Due to efficient biotransformation, PAHs are not expected to bioaccumulate (van der 
Oost et al., 2003; Hylland et al., 2009). Bioaccumulation encompass total uptake from both 
water and food and total elimination by both direct excretion and metabolism (van der Oost et 
al., 2003). Uptake, metabolism and elimination of APs are suggested to vary with compound, 
exposure route and fish species (Jonsson et al., 2008).  
 
Sorption of compounds to sediment and suspended particles is determined by Kow of the 
compound and by sediment characteristics, as content of organic matter, clay and moisture, 
and presence of oil or metals. Sorption influence partition of compounds discharged to 
receiving environment and determines bioavailability. Bioavailability is the fraction of 
compound that can be taken up in organisms’ tissues over its lifetime (van der Oost et al., 
2003). 
 
1.5 Biotransformation  
After initial absorption exogenous compounds are either excreted in parent form or 
biotransformed and excreted as metabolites (van der Oost et al., 2003). Biotransformation 
generally produces a less lipophilic metabolite, easier to excrete and less toxic than the parent 
compound (Goksoyr and Forlin, 1992). Biotransformation can result in formation of a more 
harmful compound (van der Oost et al., 2003).  
 
Oxidation, hydrolysis and reduction reactions are usually first steps in biotransformation and 
introduces or unmasks functional groups (van der Oost et al., 2003). Biotransformation in fish 
is primarily initiated by oxidation reactions (Goksoyr and Forlin, 1992) catalysed by CYPs 
which are membrane bound heme-proteins predominantly located in endoplasmic reticulum 
of the liver. Oxidation is a cycle of reactions initiated when substrate binds to the enzyme. 
Substrate binding enable reduction of ferric iron (Fe
3+
) to ferrous state (Fe
2+
) by transfer of 
electrons from nicotinamide adenine dinucleotide phosphate (NADPH) cytochrome P450 
reductase. Ferrous iron binds molecular oxygen (O2). Interrupting the cycle at this stage 
produces and releases superoxide radical (O2
-
). By adding a proton and a second electron from 
either NADPH cytochrome P450 reductase or cytochrome b5, Fe
2+
O2 is converted to 
Fe
2+
OOH. Introducing a second proton cleaves the O-O bond yielding a substrate radical, 
which is oxidized by transfer of oxygen from the FeO
3+
 complex and released. Interrupting 
the cycle after addition of the second electron results in release of hydrogen peroxide (H2O2) 
(Parkinson and Ogilvie 2007). Uncoupling the catalytic cycle can contribute to toxicity of 
compounds since ROS are formed (van der Oost et al., 2003). Enzymes catalysing 
biotransformation of exogenous compounds are involved in metabolism of endogenous 
compounds (Goksoyr and Forlin, 1992).    
 
Levels and activity of CYP 1A can be modulated by organic compounds in vitro (Hahn et al., 
1993; Brüschweiler et al., 1996; Hahn et al., 1996; Jung et al., 2001) and in vivo (Hasselberg 
et al., 2004b; Sturve et al., 2006) via AhR (Hahn et al., 1993), which is a basic helix-loop-
helix PER-ARNT-SIM (bHLH-PAS) transcription factor. Inactive AhR is primarily present in 
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cytosol (Hahn, 1998). Binding of agonist to AhR activates the receptor which dissociates from 
accessory proteins and combine with aryl hydrocarbon nuclear translocator (ARNT) via PAS 
domains (Gu et al., 2000). The complex consisting of AhR, ARNT and agonist interacts with 
xenobiotic response elements (XREs) in promoter regions of responding genes resulting in 
recruitment of co-activators and general transcription factors and transactivation (Safe, 2001). 
Increased level and activity of CYP 1A are observed after exposure to PAHs (Smeets et al., 
1999; Fent and Bätscher, 2000), a mixture of C4-C7 APs (Hasselberg et al., 2004b), and  
NPAHs (Jung et al., 2001). Other CYPs are generally less responsive to exposure for 
exogenous compounds (Celander et al., 1993; Hasselberg et al., 2004b). Toxic responses seen 
after activation of AhR are epithelial changes, porphyria, liver damage, thymic involution, 
cancer, teratogenicity, severe wasting syndrome and death (van der Oost et al., 2003). 
Activation of the AhR pathway may affect other receptor controlled pathways by sequestering 
ARNT or other limiting factors (Safe, 2001), steric hindrance at promoter regions (Klinge et 
al., 1999), increased degradation of other receptors or signal transducers (Safe and McDougal, 
2002). The crosstalk between the AhR pathway and the oestrogen receptor pathway is an 
example of this (Matthews and Gustafsson, 2006). A common perception of the endogenous 
role of AhR and what compound could be the endogenous ligand of AhR is not firmly 
established (Nguyen and Bradfield, 2008). Having similar binding affinity as the known 
potent CYP 1A agonist, tetrachlorodibenzodioxin (TCDD), 2-(1-H-indole-3-carbonyl)-
thiazole-4-carboxylic acid methyl ester is suggested as a possible endogenous ligand for AhR 
(Henry et al., 2006).  
 
Biotransformation proceeds with conjugation reactions attaching endogenous groups to 
functional groups introduced or exposed by hydrolysis, oxidation or reduction reactions 
(Jancova et al., 2010). The endogenous group is often large and polar, as for instance sugars 
or amino acids (Parkinson and Ogilvie, 2008). Conjugation reactions are sulphonation, 
glucoronidation, acetylation, methylation and conjugation with GSH and amino acids 
(Parkinson and Ogilvie, 2008). Glucoronic acid conjugates excreted via bile were identified as 
main excretion pathway after intramuscular injections of short- and medium-chain APs in 
Atlantic cod (Jonsson et al., 2008). Monohydroxy metabolites of carbazole have been detected 
in bile of rainbow trout after oral exposure (Hellou et al., 2002). Metabolites of PAHs in bile 
are found as hydroxylates or conjugated to sulfate, glucoronide or GSH (Grung et al., 2009). 
Levels of conjugation enzymes are suggested to be regulated via AhR (Bock et al., 1990) and 
also cofactors used in conjugation reactions are found to be responsive to exogenous 
compounds (Lindström-Seppä and Oikari, 1990). 
 
In cellular defence GSH has several, potentially conflicting, roles (van der Oost et al., 2003). 
It protects the cell against oxidative stress as both a cofactor in reactions catalysed by GPx 
and a major non-enzymatic antioxidant, and it is also an important co-factor in conjugation 
reactions with electrophilic compounds (Forman et al., 2009). To maintain GSH:GSSG ratios 
GSSG is continuously reduced to GSH catalysed by GR. One GSSG is reduced to two GSH 
by oxidizing one molecule of NADPH (Halliwell and Gutteridge, 1989). De novo synthesis of 
GSH is induced by exposure to electrophilic compounds (Forman et al., 2009)  
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Responsiveness of AhR and induction of CYP are indicated to be dependent on cells thiol 
status, suggesting a crosstalk between the CYP system and GSH system (Otto et al., 1996; 
Otto et al., 1997) 
 
1.6 Genotoxicity 
Produced water relevant compounds are suggested to enhance amount of DNA damage direct 
and indirect, indirect through formation of ROS by enhanced CYP 1A activity and by 
affecting the glutathione dependent defence system (Halliwell and Gutteridge, 1989; van der 
Oost et al., 2003; Hasselberg et al., 2004a).  
 
Damage to DNA can be caused by exogenous and endogenous agents or spontaneous due to 
intrinsic instability of DNA (Altieri et al., 2008). Recently, DNA double strand breaks (DSB) 
have been suggested to be due to failure of enzyme tethers during normal replication and 
repair (Bignold, 2009).  
 
Oxidation of DNA by ROS is a major source of DNA damage. Derivatives of oxygen, O2
-
, 
hydroxyl radical (OH
•
) and H2O2 are examples of ROS. Damages identified after oxidation of 
DNA by ROS include single and double DNA strand breaks, purine, pyrimidine or 
deoxyribose modifications and DNA cross links (Valko et al., 2006). When ROS exceeds 
cellular antioxidant defence capacity the situation is termed oxidative stress (Altieri et al., 
2008). Effects of oxidative stress are counteracted by action of antioxidants and antioxidant 
enzymes. Important non-enzymatic antioxidants are thiol antioxidants (Valko et al., 2006). 
The major thiol is GSH (van der Oost et al., 2003). Antioxidant enzymes are catalase, 
peroxidases and superoxide dismutases (Halliwell and Gutteridge, 1989). 
 
Several processes can enhance oxidative stress (Halliwell and Gutteridge, 1989). Redox 
cycling produces O2
-
 when a reduced reactive metabolite reacts with O2. The process converts 
the metabolite back to the parent compound, contributing to oxidative stress and depleting 
redox potential in the cell by oxidizing one reductant per cycle (Halliwell and Gutteridge, 
1989). Redox active compounds are aromatic diols, quinones, nitroaromatics and aromatic 
hydroxylamine (van der Oost et al., 2003). Uncoupling CYPs oxidative cycle produces O2
-
 
(Bondy and Naderi, 1994). By modulating quantity and activity of CYP 1A enzymes, 
compounds can indirectly enhance oxidative stress in a cell, as suggested for APs in Atlantic 
cod (Hasselberg et al., 2004a). 
 
Reactive electrophilic compounds can interact with DNA and cause a variety of modifications 
and damages (Klaunig and Kamendulis, 2008). Potent DNA reactive compounds are assumed 
to be PAHs with bay regions, fjord regions or sterically hindered bay regions. 
Biotransformation of BaP yields more potent DNA reactive compounds and also redox active 
compounds, Fig. 1.5 (Baird et al., 2005). A general approach to study mechanisms and 
potential for compounds to cause genetic damage is to assess extent of DNA stand breaks 
(van der Oost et al., 2003). 
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Figure 1.5. Biotransformation of BaP to diol epoxides. Biotransformation of PAHs is initiated by CYP 1A 
converting lipophilic PAHs to reactive electrophiles by adding an epoxide group. The electrophile intermediates 
can be conjugated and excreted. Biotransformation of PAHs may result in formation of DNA reactive PAH diol 
epoxides when the epoxide group is converted to diolhydro diol by epoxide hydrolase. Adding another epoxide 
to the compound catalysed by CYP 1A creates the electrophilic intermediate diol epoxide. The most potent DNA 
reactive compound is the BaP-7,8-diol-9,10-epoxide (Baird et al., 2005). 
 
 
Repair mechanisms have evolved to protect DNA against damage. Most repair pathways are 
initiated by excision and resynthesis of the damaged area using the complementary strand as a 
template. Repair of minor DNA damages are usually processed via one of three pathways: 
The DNA base excision repair, the nucleotide excision repair (NER)PAH, or the general DNA 
mismatch repair. Two interconnected pathways repair DNA DSB; homologous recombination 
(HR) and non-homologous end joining (Altieri et al., 2008). Cells deficient in repair pathways 
are shown to be more sensitive towards damage induced by BaP-7,8-diol-9,10-epoxide 
compared to cells with intact repair mechanisms (Meschini et al., 2008).  
 
1.7 In vitro studies  
Harmful compounds can cause adverse effects on several levels of biological organization, 
ranging from molecular to ecosystem level. Potential toxic effect of compounds can be 
studied in situ, and in laboratories in vivo and in vitro. Cellular responses are usually the first 
manifestations of toxicity since the first interaction between compounds and biological 
systems is at the cellular or molecular level. Such interaction can be common across species 
(Fent, 2001). Identifying and understanding common and unique mechanisms of toxicity can 
enhance extrapolation of toxicity between species (Castaño et al., 2003). In vitro studies are 
valuable for examining cellular responses and as first line evaluation of compounds (Fent, 
2001).  
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Continuous cell lines can be used in assays evaluating basal cytotoxicity of compounds and in 
assays studying specific endpoints like genotoxicity and CYP 1A induction (Babich et al., 
1991; Fent, 2001). In vitro assays examining AhR mediated gene expression or CYP 1A 
enzyme activity are versatile when studying interaction in complex mixture of compounds 
with dioxin-like properties (Villeneuve et al., 2001).  
 
Cytotoxicity in vitro correlates with in vivo acute fish toxicity (Babich et al., 1991). However, 
in vitro laboratory studies are limited when tissue-specific toxicity, adaptive responses and 
metabolic conversion are important. Effects seen in laboratory studies can be extrapolated to 
environmental exposure with restrictions (Fent, 2001). The success of extrapolating in vitro 
results will partly be determined by how well the cell line represents the tissue it is derived 
from (Babich and Borenfreund, 1991; Ryan and Hightower, 1994). 
 
All fish cell lines are usually anchorage dependent and grow in monolayer (Babich and 
Borenfreund, 1991). The cell line used in this master project, PLHC-1 was initiated from a 
hepatocellular carcinoma. The original tumour was induced chemically in a desert topminnow 
(Poeciliopsis lucida) by using 7,12-dimethylbenz(a)anthracene. Cells of the cell line are 
epithelial-like and still maintain features of original liver functions (Ryan and Hightower, 
1994), one of which is the CYP activity. The activity of CYPs is inducible (Babich et al., 
1991) through binding of a ligand to the AhR (Hahn et al., 1993). The cells are metabolically 
active and can activate secondary toxicants (Babich et al., 1991). Very low levels of ER 
mRNA are detected in PLHC-1 (Fent, 2001). 
 
1.8 Combined action in mixtures and analysis of mixtures 
Simple similar action, simple dissimilar action and interaction are three basic concepts 
describing combined action of compounds in biological systems (Groten, 2000). Simple 
similar action is when each compound acts in the same way and by the same mode of action, 
only differing in their toxic potencies. Simple similar action is also called concentration or 
dose addition. Chemicals with simple dissimilar action have different modes of action and 
also possibly different target sites, and are not expected to influence the toxic effect of each 
other. This is also called response addition. Correlation of susceptibility of exposed biological 
systems to compounds with simple dissimilar action is described by complete negative 
correlation, complete positive correlation or no correlation (Groten, 2000). 
 
Combined exposure to compounds resulting in stronger or weaker effect compared to what is 
expected based on additive combined effect, is known as interaction. Stronger effect can be 
caused by synergism, potentiation or supra-additive effects and weaker effect by antagonism, 
sub-additive effects or inhibition. The cause of interaction can be physiochemical or 
biological (Groten, 2000).  
 
Complex mixture can be studied by several approaches including whole mixture analysis and 
component interaction analysis (Groten, 2000). Statistical designs are useful when studying 
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interaction between compounds in mixtures (Cassee et al., 1998), since carefully selected 
samples increase the chance of obtaining useful information from data.  Statistical designs are 
screening designs or optimising designs. Screening designs are used when the purpose is to 
identify the most important variable, while optimising designs are used when variables are 
studied at more than two levels. Results from experiments using experimental design can be 
studied by analysis of variance (ANOVA), multiple linear regression (MLR) and by 
projection methods such as principal components analysis (PCA) and projection to latent 
structure by partial least squares (PLS) (Esbensen, 2000). Grouping responses and important 
variables can be done using PCA, while PLS correlates variation in a set of predictor variables 
with variation in response(s) (Feron and Groten, 2002).  
 
1.9 Aims and hypothesis 
Produced water is a complex mixture discharged to sea in high volumes containing 
compounds at low concentration. Combined exposure of compounds can modify predicted 
effect based on single exposure. To have knowledge about potential interactions in produced 
water is important. Carbazole is present in produced water and is suggested to contribute to 
CYP 1A inducing potential of produced water. Studies performed on toxicity of carbazole in 
relation to produced water are limited.   
  
Increased or decreased EROD activity indicates interaction between compounds and 
biological system. Enhanced activity of biotransformation enzymes has potential to increase 
oxidative stress in organisms and produce active metabolites.  
 
The aims of this master project are to determine carbazoles potential for modifying CYP 1A 
activity measured as ethoxyresorufin-O-deethylase (EROD) activity, to evaluate interaction in 
ternary mixtures with carbazole and two compounds representing fractions contributing to 
toxicity of produced water, and also to study correlation between biotransformation activity 
and genotoxicity by measuring DNA double strand breaks (DSB).  
 
The aims are achieved by studying EROD activity in vitro in the continuous cell line PLHC-1 
after single and combined exposure to the compounds. To best evaluate interaction a 
statistical design is used. Results are analysed with PLS. Compounds included are DMP, 
carbazole and BaP. Concentrations used in the design are determined by considering 
cytotoxicity results obtained with MTT cytotoxicity assay, EROD concentration effect curves 
for single compounds and environmentally relevant concentrations.  
 
It is hypothesized that compounds will modify EROD activity different when present in 
ternary mixtures compared to single exposure. It is suggested that ternary mixtures inducing 
high EROD activity will produce a higher degree of DNA DSB in PLHC-1 cells. Carbazole is 
suggested to modify EROD activity induced by the other compounds.   
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2 MATERIALS AND METHODS 
2.1 Cell line  
Since effects of aquatic environmental contaminants are studied in this master project, a cell 
line from an aquatic organism, PLHC-1, was chosen as in vitro study system. Continuous cell 
lines have potential for numerous passages (Fryer and Lannan, 1994) and are valuable in 
long-term studies providing information about toxic compounds in the same biological system 
making direct comparison of compounds possible (Fent, 2001). Primary interactions between 
biota and compounds are at cellular levels making studies with cell cultures important (Fent, 
2001). Cells from PLHC-1  is in previous considerations at our lab found better suited for 
evaluating aquatic contaminants than other fish cell lines, as RTG-2.  
 
The origin of PLHC-1 is from a hepatic tumour formed in a desert topminnow (Poeciliopsis 
lucida) after multiple exposures to 7,12-dimethylbenz(a)anthracene (Ryan and Hightower, 
1994). A positive trend between cytotoxicity in vitro in PLHC-1 and acute toxicity in fish in 
vivo has been reported. In initial evaluation and estimation of aquatic toxicity of chemicals 
PLHC-1 is seen as a valuable tool (Fent and Hunn, 1996). Cell cultures are a rapid, ethical, 
economical and scientifically beneficial test system for first line evaluation of the toxic effects 
of both single chemicals and mixtures of chemicals.   
 
Important tissue-specific functions are still maintained in PLHC-1, as CYP activity (Ryan and 
Hightower, 1994) which is inducible through the aryl hydrocarbon receptor (AhR) (Hahn et 
al., 1993). Induction of stable CYP 1A is shown after exposure to PAHs and PLHC-1 cells are 
considered metabolically active cells (Brüschweiler et al., 1996).  
 
2.2 Cultivating cells  
 
2.2.1 Materials and chemicals 
Materials, chemicals and solutions used when cultivating cells are presented below. 
Composition of the solutions is presented in Appendix 1. 
 
 
Materials Catalogue number Producer 
Autoclave SX-700E TOMY 
Automated pipette, battery 
operated 
4-00-031 Drummond scientific 
Balance  Mettler AE 260 DeltaRange 
Cell cultivating flasks, 75 cm
2
 83.1813 Sarstedt 
Centrifuge 3-10 Sigma 
Centrifuge tubes 347856118559 Nunc 
Cryo tubes 2 mL 479-0281 WR International 
 3111 Forma Scientific 
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Incubator cabinet (CO2 water 
jacketed incubator, 3111) 
Magnet stirrer 02075125 Gerhardt Bonn 
Microscope TS100 Nicon eclipse 
Nitrogen container HCB00B137 Thermolyne 
pH-meter PHM210 Radiometer Copenhagen 
Pipettes   
200 µL X51993J Gilson 
1000 µL X52776K Gilson 
5000 µL 022492080 Eppendorf 
Pipette tips   
200 µL 70.760.502 Sarstedt 
1000 µL 70.762.100 Sarstedt 
5000 µL 022492080 Eppendorf 
Sterile hood S-2010 1.2 Heto Holten AS 
Sterile pipette tips   
25 mL 86.1685.001 Sarstedt 
 
 
Chemical Catalog number Producer 
Dimethylsulfoxide (DMSO, 
spectrophotometric grade) 
1.02950 Merck 
Disodiumhydrogenphosphate 
(Na2HPO4*2H2O) 
1.06580 Merck 
Ethanol, 96% 24106 Sigma 
Ethylenediaminetetraaceticacid 
disodium salt dihydrate (EDTA, 
99+%) 
E-5134 Sigma 
Foetal Bovin Serum (FBS) F3018 Sigma 
Minimal Essential Medium (MEM) M4655 Sigma 
Penicilin-Streptomyocin 15070-063 Gibco 
Potassiumchloride (KCl) 1.04936 Merck 
Potassiumdihydrogenphosphate 
(KH2PO4) 
1.04873 Merck 
Sodiumchloride (NaCl) S-3014 Sigma 
Trypsin, 2.5% 15090-046 Gibco 
 
 
Solutions   
MEM-Growth Medium   
Phosphate buffered saline (PBS)   
Trypsin, 2.5% with 1% EDTA 
EDTA 
  
 
2.2.2 Procedure for cultivating cells 
Cells from PLHC-1 were received from the American Type Culture Centre autumn 2006 and 
stored in liquid nitrogen. Cells were retrieved from liquid nitrogen 11.11.2009, briefly 
thawed, and transferred to a 75 cm
2
 cell cultivating flask containing preheated growth 
medium (20 mL). Cells were grown in a humidified atmosphere (30 °C, 5% CO2). Fresh room 
tempered medium was supplied every second day and 24 hours before starting an experiment.   
 
Sub culturing was performed when cells were confluent. Growth medium was removed and 
the flask briefly rinsed with room tempered phosphate buffered saline (PBS) followed by four 
minutes incubation with 0.05% Trypsin (2.5% Trypsin with 1% EDTA) in PBS. Suspended 
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cells were transferred to centrifuge tubes and centrifuged for five minutes at 1188 rounds per 
minute (rpm). The supernatant was removed by gentle pouring and the cell pellet was 
suspended. Cells were centrifuged a second time (1188 rpm) for five minutes in PBS (10 mL). 
Supernatant was removed and the cells suspended in growth medium (1 mL), and the desired 
cell dilution(s) (between 25% and 12.5 %) were transferred to cultivating flask(s) with 
preheated growth medium (20 mL).  
 
Procedure for preparing cells for storage in liquid nitrogen was performed as described above 
for sub culturing cells until suspending cell pellet after the second centrifugation. After 
removing the supernatant, the pellet was suspended in growth medium (0.5 mL) and 
transferred to a cryo tube with growth medium (0.5 mL, 10% DMSO). Cryo tubes containing 
cells were frozen (-80 °C, 1h) before they were transferred to liquid nitrogen. Cells were sub 
cultured approximately 30 times before a fresh batch was started.  
 
2.3 MTT cytotoxicity assay 
Cytotoxcity was asses using the MTT-assay according to Mosmann (1983). The MTT assay 
uses activity of various dehydrogenase enzymes which catalyse cleavage of a tetrazolium ring 
in the tetrazolium salt, 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
salt, as a measure of cell viability. Cleavage of the tetrazolium ring form insoluble formazan 
crystals. The formazan crystals can be solubilized in dimethyl sulfoxide (DMSO) and 
absorbance measured with a plate reader at 550 nanometer (nm).  
 
2.3.1 Materials and chemicals 
Materials, chemicals and solutions listed below were used. Composition of the solutions is 
given in Appendix 1.  
 
 
Materials Catalogue number Producer 
Costar sterile 96-well plate 3599 Corning Incorporated 
Haemocytometer Debt 0.1 mm Brand 
Multichannel pipette 3238643 Eppendorf 
Spectrophotometric plate reader 354-00578 Labsystems 
Sterile tubes   
15 mL 62.554.502 Sarstedt 
50 mL 62.547.254 Sarstedt 
 
 
Chemicals  Catalogue number Producer 
Thiazolyl Blue Tetrazolium Bromide 
(MTT, ~98%) 
M2128 Sigma 
2,5-dimethylphenol (99% GC-MS)*   
Benzo(a)pyrene (97% HPLC) B-1760 Sigma 
Carbazole (96%)  Aldrich 
Phenanthrene (neat) 4-8564 Supelco 
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Solutions   
MTT-solution   
MTT/medium-solution   
Test solution    
 * Analysed at the Department of chemistry, NTNU, by Rudolf Schmid 
 
 
2.3.2 Procedure for the MTT assay 
2.3.2.1 Linear area of formazan formation  
Cytotoxic effect of compounds is more precisely determined if cell concentration is within the 
linear area of formazan formation. The linear area was determined by measuring formazan 
formation for a range of cell concentrations. Cells were treated as described for sub culturing. 
The last 1 mL growth medium containing suspended cells was diluted 1 to 10 (1:10) and 
concentration was determined by placing 30 µL of the 1:10 dilution on each of the two grids 
on a haemocytometer. Cells were counted in a defined area (0.0001 mL) on the grid. Counting 
was repeated three times on each grid. Cell concentration (cells/mL) in the 1:10 dilution was 
average value of the six parallels.  
 
After determining the concentrations of the cell suspension, ten dilutions were made from the 
1:10 dilution and seeded in six parallels on a 96 well plate. Edge wells were kept empty, but 
filled with medium or DMSO in order to avoid excess evaporation during incubation and edge 
effects when reading the result, respectively.  
 
Plates were incubated for 96 hours. Fresh growth medium (200µL per well) was supplied 
after 24 hours to mimic exposure scenarios. After 96 hours incubation, growth medium was 
replaced with MTT/medium solution (200 µL). Plates were incubated for four hours before 
DMSO (200 µL) was added to stop the reaction and solubilize the crystals that had been 
formed. Absorbance was read at 550 nm with a plate reader. Results are presented as average 
absorbance ± standard deviation, cell concentration is concentration seeded on the first day. 
Well absorbance values that are ± two standard deviations from average values are considered 
to be outliers and removed from the average. These are marked with asterisk in Appendix 2.  
 
2.3.2.2 MTT cytotoxicity assay 
Cells were sub cultured (Chap. 2.2.2.) and cell concentration in the 1:10 dilution determined 
(Chap. 2.3.2.1.) as described above. Cells were seeded on a sterile 96-well plate at 
concentrations within the linear area of formazan formation. After incubation for 24 hours, 
cells were exposed to the test solution and incubated for 48 hours. At 96 hours after seeding 
MTT/medium solution (200 µL) was added, plates incubated for four hours and reaction 
stopped by adding DMSO (200 µL). Absorbance was read at 550 nm with a plate reader. 
 
Cytotoxicity was determined by two or more independent experiments with six parallels for 
each concentration or mixture. Cytotoxicity is expressed as average per cent cell survival ± 
2 Materials and methods 
17 
 
standard deviation, in relation to the DMSO control. The cell survival for DMSO control is set 
to 100 %. The individual parallels with absorbance values ± two standard deviations from 
average values were considered to be outliers and were excluded from the average.  
 
2.4 CATALYTIC EROD ACTIVITY 
Measuring EROD-activity was performed as described in Fent and Bätscher (2000) with 
modifications and presented per mg protein using the BioRad protein assay solution as 
described in Bradford (1976). Procedure for both assays and modifications of EROD assay 
are described below.  
 
2.4.1 Bradford total protein assay 
To correct for variation in protein amount, EROD activity is presented per milligram protein.  
 
2.4.1.1 Materials and chemicals 
Materials, chemicals and solutions used when determining total protein are presented below. 
Total protein was determined on the same sample material as used for determining EROD 
activity, exposure conditions and harvesting is described below. Composition of the solution 
is given in Appendix 1.  
 
 
Materials  Catalogue number Producer 
Spectrophotometric plate reader 354-00578 Labsystems 
Unsterile 96-well plate 650-001 Greiner bio-one 
 
 
Chemicals Catalogue number Producer 
BioRad protein assay solutions 500-0006 BioRad 
Bovine Serum Albumin (BSA) B4287-56 SigmaAldrich 
 
 
Solutions   
BSA   
 
 
2.4.1.2 Procedure for the Bradford assay 
Unsterile 96-well plates were used when setting up the Bradford assay. A standard curve with 
known concentrations of protein was included in triplicate on each plate. First, BioRad protein 
assay solution (40 µL) was added to all wells. The standard curve was prepared, including 
points at 0, 5, 10, 15, 20, 30, 40 and 50 µg protein per mL. After adding the required amount 
of BSA, final volume of the wells was adjusted to 200 µL. The standard curve was completed 
before samples (4µL) were loaded in remaining wells in triplicate. Final volume was adjusted 
by adding milliQ-water (156 µL). Samples, BioRad protein assay solution and milliQ-water 
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were mixed with a multichannel pipette, and any bubbles formed were removed by using a 
hypodermic needle. The plate was incubated for five to 60 minutes before absorbance was 
read at 595 nm. 
 
Amount of protein of a sample were average values three parallels. Parallel values were 
individually evaluated and disregarded from subsequent calculations if found deviating. These 
parallels are marked with an asterisk in Appendix 3. 
 
2.4.2 EROD assay 
EROD activity was determined by measuring fluorescence in intervals of 60s for 17 minutes 
at excitation and emission wavelengths of 530 and 590 nm, respectively. The substrate, 7-
ethoxyresorufin (ER) is converted to resorufin by deethylation catalysed by CYP 1A 
enzymes. Fluorescence data is fitted to a resorufin standard curve for quantification, presented 
in Appendix 3.  
 
2.4.2.1 Materials and chemicals 
Materials, chemicals and solutions used in the EROD assay are presented below. Composition 
of the solutions is presented in Appendix 1.  
 
 
Materials  Catalogue number Producer 
Eppendorf tubes   
1.5 mL 72.690.001 Sarstedt 
0.5 mL 72.699 Sarstedt 
Half area 96 well plate, unsterile 675096 Greiner bio-one 
Multichannel pipette 3238643 Eppendorf 
Plate reader 1010-1 Synergy HT 
Costar Sterile 24-well plate 3524 Corning Incorporated 
 
 
Chemicals Catalogue number Producer 
2,5-dimethylphenol (99% GC-MS)   
7-ethoxy resorufin  E3763 Sigma 
Bovine Serum Albumin (BSA) B4287-56 SigmaAldrich 
Benzo(a)pyrene (97% HPLC) B-1760 SigmaAldrich 
Carbazole (96%)  Aldrich 
NADPH N-7505 SigmaAldrich 
Trizmabase  T6066 SigmaAldrich 
 * Analysed at the Department of chemistry, NTNU, by Rudolf Schmid 
 
 
Solutions   
Bovine Serum Albumin (BSA)   
7-ethoxyresorufin   
NADPH   
Tris   
 
2 Materials and methods 
19 
 
2.4.2.2 Procedure for the EROD assay 
Cells from a confluent cultivating flask were seeded in wells on a sterile 24 well plate. After 
incubation for 24 hours, growth medium was replaced with test solution (1 mL). Cells were 
incubated with test solution for eight hours. Test solution was removed and each well was 
rinsed with PBS (1 mL) before the plate was wrapped in aluminium foil and frozen (-80 °C). 
Plates were stored in the freezer until enzyme activity was determined. Length of freezing has 
previously been shown not to affect enzyme activity (Renate Haldsrud, pers. comm).  
 
When assessing enzyme activity the plate was removed from the freezer, briefly thawed and 
tris (160 µL) was added to each well. The plate was wrapped in aluminium foil and frozen (-
80 °C, 30-60 minutes). The plate was thawed (10 minutes) and tris with cell debris was 
transferred to autoclaved 0.5 mL eppendorf tubes. The tris solution was pipetted up and down 
forcefully in the well 5-10 times to loosen as much cell debris as possible. Eppendorf-tubes 
were kept on ice after the samples were transferred to the tubes.  
 
Enzyme activity was measured by adding sample (50 µL) in two wells horizontally on a black 
half-area 96-well plate. The assay included four parallels of blanks with tris (50 µL). After 
samples were added, BSA (20 µL, 5.32 mg/mL in 50 mM tris, pH 7.8) was added to each 
well, then ER (80 µL, 4 µM in 50 mM tris, pH 7.8). The plates were incubated (25 °C for 15 
minutes) with continuous shaking (30rpm), before NADPH (20 µL, 6.7 µM in 50 mM tris, pH 
7.8) was added. Total volume in the wells was 170 µL.  
 
The plate reader that was used to set up the standard curve used for quantification (µM 
resorufin) was also used for analyses in this master project. Results are blank corrected and 
presented as average values of three parallels ± standard deviation, as pmol resorufin per 
minute per mg protein. Values for EROD activity are negative for certain mixtures and 
concentrations. This is because low fluorescence values are outside the range of the standard 
curve. These values were not adjusted to zero values, since they represent a change in EROD 
activity relative to DMSO control. When interpreting negative values, DMSO control 
presented in figures are considered.  For ternary mixtures, EROD activity after exposure to 
DMSO was -203 pmol resorufin/min/mg protein.  
 
Three parallels for each concentration or mixture were included when determining EROD 
activity. Two and three parallel samples were included for each of these parallels when 
measuring fluorescence and total protein, respectively. Calculations were performed 
individually for the three parallels, while EROD activity is presented as average values of 
these. 
 
Assessing EROD activity involves two procedures and several steps and is assumed to be 
sensitive to error. Fluorescence values are individually evaluated and disregarded from 
subsequent calculations if found deviating. These are marked with asterisk in Appendix 3. 
Parallel samples which are removed are marked with grey shade in Appendix 3. Three or 
more independent experiments were performed with each mixture or compound. 
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2.4.2.3 Optimization of protocol 
The protocol was modified from a protocol presented by Fent and Bätscher (2000). Changes 
are listed sequentially as they were performed below and are illustrated in Fig. 2.1. 
 
Fent and Bätscher 2000 
Catalytic EROD activity was determined according to the original protocol except cells were 
seeded on 24 well plates and not 96 well plates as in the original protocol. Due to this change, 
cells had to be harvested as described above.  
 
Incubation 
Incubation for 15 minutes at room temperature as presented in the original protocol was 
changed and performed in an incubator at 25 °C to avoid fluctuating temperature conditions. 
 
ER concentration 
The area of a well on a 24 well plate is approximately six times bigger than the area of a well 
on a 96 well plate (2.3 cm
2
 and 0.38 cm
2
, respectively). Based on the size difference between 
wells and the amount of cell suspension added to each well when assessing enzyme activity, it 
was assumed that the amount of cell content present was approximately doubled compared to 
the original protocol. It was assumed that higher amount of enzymes required more ER, and 
the amount or ER added to each well was doubled.  
  
NADPH concentration 
As the enzyme activity increased after doubling the ER concentration, doubling of the 
NADPH concentration was evaluated.  
 
Harvesting 
Cells had to be properly lysed to get enough material for determining enzyme activity and 
total protein on the same sample material. Plates were in initial experiments freezed, thawed, 
and added tris before samples were collected. To improve cell lysis and detachment from well 
bottom, plates were frozen (-80 °C, 30 to 60 minutes) also after tris had been added.  
 
Harvesting (2) 
Based on the increase in enzyme activity observed after freezing plates with tris, it was 
examined if three sequential freezing/thawing cycles could increase cell lysis and amount of 
cell content in samples further. 
 
Seeding density (70% and 50%) 
It was contemplated if dense growth conditions could decrease enzyme activity in cells. This 
was assessed by seeding only 70% and 50% of the 1 mL cell suspension.   
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Eight hours exposure (8h) 
Protein induction is a rapid response (Ryan and Hightower, 1994) and optimal exposure time 
for 10
-4
 mg/mL BaP has previously been shown to be eight hours (Smeets et al., 1999). The 
effect of a exposure time of eight hour was evaluated. 
 
Reproducing 8h 
The preliminary protocol was reproduced.  
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Figure 2.1. Sequential modifications of original protocol for EROD assay presented by Fent and Bätscher 
(2000).  The EROD assay was first performed as described in the original protocol, but with changed growth 
conditions, Fent and Bätscher, 2000, then incubation, ER concentration, NADPH concentration cell lysis,  
seeding densities (70% and 50 %) and exposure conditions (8h) was changed sequentially. See text for details. 
Results obtained with the final protocol were reproduced (reproducing 8h).  
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2.5 GENOTOXICITY 
Damage to DNA was assessed as DNA DSB by separating DNA from PLHC-1 on agarose gel 
electrophoretically as described in Theodrakis (1994) and Krøkje and co-workers (2006). 
Cells from PLHC-1 exposed to ternary mixtures were casted in low melting point agarose 
(LMPA), digested and DNA from the cells separated according to size on 0.6% agarose gel. A 
high degree of DNA DSB results in smaller DNA fragments that migrate further on the gel. 
After separation, DNA fragments were stained with ethidium bromide and visualized by 
fluorescence.     
 
2.5.1 Materials and chemicals 
Materials, chemicals and solutions used for gel electrophoresis are presented below. 
Composition of the solutions is presented in Appendix 1.  
 
 
Materials  Product number Producer 
Biofuge fresco 75005510/01 Haraeus 
Cast for gel  BioRad 
Comb, 15 wells  BioRad 
Electrophoreses power supply – EPS 200, 
GN003036 
19-0200-00 Pharmacia-Biotech 
Eppendorf tubes 1.5 mL 72.690.001 Sarstedt 
GelDoc 2000  BioRad 
Heat block (Dri Block DB-2D, FDB02DD) 117995-21 Techne 
PowerPac Basic (300V, 4000 mA, 75W) 63S 28031 BioRad 
Sterile 24 well plates  Corning Incorporated 
 
 
Chemicals Product number Producer 
Agarose for routine use A9539 SigmaAldrich 
Low melting point agarose 162-0019 BioRad 
Active charcoal C3014-2 SigmaAldrich 
Boric acid (for electrophoresis, H3BO3) B7901 SigmaAldrich 
Ethidium bromide (C21H12BrN3) 161-0433 BioRad 
Lambda/Hind III marker  2 SM0101 Fermentas 
Lambda DNA SD0011 Fermentas 
Loading dye × 6 R0611 Fermentas 
Proteinase K (from Tritirachium albumin, 39 
units/mg protein) 
108K8610 SigmaAldrich 
SDS (sodiumdodecylsulfat, C12H25SO4Na) L-3771 SigmaAldrich 
Trismabase T6066 SigmaAldrich 
 
 
Solutions   
Digestion buffer   
Lambda-DNA marker    
TBE-buffer   
TE-buffer   
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2.5.2 Procedure for gel-electrophoresis  
After sub culturing, 100 µL cell suspension was seeded per well. Cells were incubated for 24 
hours before growth medium was replaced with test solutions and incubated for 48 hours with 
test solution. The cells were trypsinized (0.05 % trypsin in PBS) for three minutes. Cell 
solution was transferred to 1.5 mL eppendorf tubes and centrifuged (4000 rpm, two minutes). 
The pellet was suspended in TE-buffer (0.5 mL, 10 mM tris, 1 mM EDTA, pH 8, 30 °C) and 
LMPA (0.5 mL, 1%, 30 °C) was added. Cells suspended in TE-buffer/LMPA were transferred 
to plug moulds, 40 µL cell suspension/plug. Plugs were refrigerated (4 °C), transferred to 1.5 
mL eppendorf tubes with digestion buffer (0.5 mL, 100 mM NaCl, 10 mM tris, 25 mM 
EDTA, 0.5% SDS, pH 8, added 1 mg/mL proteinase K) and incubated at 55 °C over night. 
Plugs were cooled to room temperature and placed in wells on a 0.6 % agarose gel (10 cm), 
which were sealed with 1% LMPA. Samples were run at 23 V (2.3 V/cm) for 12 hours 
together with a marker (1 µL λDNA marker solution, 4 µL 6 × loading dye and 15 µL 
distilled water). The standard used was λDNA and λ/HIND III marker 2. The marker was 
heated to 65 °C for five minutes and put straight on ice for three minutes and transferred to 
the gel after loading the samples. After separation, DNA fragments were stained with 
ethidium bromide (0.5 µg/mL) for two hours before DNA staining intensities were analysed 
with a BioRad GelDoc 2000. From DNA staining intensities, median molecular lengths 
(MML) were estimated. From MML relative numbers of strand breaks per kilobase pair 
(RNSB/kb) was calculated. The solution containing ethidium bromide was decontaminated 
with active charcoal.  
 
2.5.3 Calculations 
Estimated MML can indicate the extent of DNA DSB in cells (Theodorakis et al., 1994). By 
considering maximum DNA staining intensity MML can be found. After analyses results are 
presented as a graph with DNA staining intensities as a function of relative front (Rf) for each 
lane, Appendix 6. Related to migration distance, Rf is a relative number between zero and 
one. Position for maximum DNA staining intensity (DNA Max.) was estimated by 
accumulating all y-values for an interval along the x-axis and dividing the accumulated sum 
by two: 
 
        
 
 
∑     
 
                                                            (2.1) 
 
The x-value for half the accumulated sum, is Rf1/2. A standard curve is made for each gel 
relating known size of the fragments in the marker to their Rf. Using the standard curve, Rf1/2 
for samples are extrapolated to MML which is expressed in kilo base pairs (kb). Length of the 
DNA fragments (Ln) can be approximated from MML by (Ehmann and Lett, 1973): 
 
                                                                        (2.2) 
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According to Freeman and co-workers (1986) RNSB are calculated from length of DNA 
fragments by: 
 
     
 
            
  
 
                    
                                (2.3) 
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2.6 Compounds and concentrations 
Carbazole is present in produced water and it is suggested to be a potential contributor to 
produced water toxicity (Ståle Johnsen, pers. comm). Information on toxic effect of carbazole 
in relation to produced water is limited. Carbazole is included in this project to study its 
potential for modifying EROD activity singly and in mixtures. It is important to have 
knowledge about interaction between compounds since mitigation measures aimed at 
reducing environmental risk of produced water discharge may be targeted on single 
compounds. Interaction is more common for high concentrations of compounds. The aromatic 
and phenolic fractions of produced water are significant contributors to toxicity of produced 
water (Johnsen et al., 1994; Utvik, 1999) and two compounds representing each of these 
fractions are included in this master project. The compounds selected as representative 
compounds are measured at high concentrations relative to other compounds in same fraction.  
 
Compounds are included at concentrations that are environmentally realistic. Phenanthrene 
was included to represent aromatic fraction, while DMP was included to represent phenolic 
fraction. Phenanthrene is one of the NPDs which are dominating polycyclic compounds in 
produced water. The short-chain APs are less studied compared to the long-chain APs and are 
more relevant for produced water.  
 
Phenanthrene was due to practical reasons replaced by BaP. Homogenous test solutions of 
phenanthrene could not be made at the desired concentrations in initial MTT cytotoxicity 
assay. The consequence was highly varible results. As phenanthrene, BaP is a PAH and it is 
detected in the marine environments (Utvik, 1999; Harman et al., 2009).  
 
A statistical design was used to vary concentrations of the compounds in ternary mixtures 
systematically. Concentrations included in the design were chosen based on cytotoxicity (Fig. 
3.2-3.4), concentration-effect curves for single compounds (Fig. 3.6-3.8) and measured 
concentrations of the compounds in marine environment, Appendix 4. 
 
2.7 Statistical designs  
Mathematical protocols for experimental designs are developed so that all variables 
influencing a system can be changed simultaneously without losing experimental control 
(Esbensen, 2000). Such experiments are more robust in terms of obtaining the correct 
information (Wold et al., 2001). The effect of changing one variable at the time is illustrated 
in Fig. 2.2.  
 
Different types of statistical designs can be used depending on the purpose of the study. 
Screening designs identifies which variables are most important in modulating the measured 
response. Full and fractional factorial designs can be used for screening. In a full factorial 
design, all combinations of high and low are included. For three variables this can be 
illustrated as a cube where variables are varied from low to high in three directions(Esbensen, 
2000). Experiments are placed in each of the eight corners of the cube. For a two level full 
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factorial design with k variables, 2
k
 experiments are generated. If many variables are present 
this can result in numerous experiments (Wold et al., 1986). Studies of a large number of 
variables can be performed with fewer experiments using fractionate factorial designs 
(Esbensen, 2000).  
 
 
Figure 2.2. Ridge plot showing a process influenced by two process variables and a full factorial design. By 
changing one variable at the time the experiment identifies the ridge where the response is higher. The response 
is lowered again when the other variable is changed in steps. Highest response is identified as the +. The actual 
peak is missed (Wold et al., 1986). 
 
Statistical designs including variables at more than two levels are Box-Behnken and Central 
Composite designs. The Box-Behnken design combines variables so that high levels of all 
variables are not present at the same time in any experiment. For a design with three variables 
this can be illustrated by placing experiments in the middle of all lines of a cube. The lines of 
the cube are the concentration range of the variables included from low to high (Esbensen, 
2000).  
 
A Central Composite design includes high levels of all variables. For a design with three 
variables it can be illustrated as a full factorial design with a sphere around with six 
experiments placed on the surface of the sphere extending from the middle of each face of the 
cube. Experiments placed on the sphere have a higher concentration of the variables than high 
concentration in the full factorial design. A variant of the Central Composite design is the 
Central Composite design Face Centred (CCF) (Esbensen, 2000). This design includes a full 
factorial design with experiments positioned on the face of the cube instead of outside the 
cube, Fig. 2.3.  In this master project, a CCF was used to design 17 mixtures. 
 
Composition of the 17 ternary mixtures with high, medium and low concentration of DMP, 
carbazole and BaP included in this project is presented in Table 2.1. Stock solutions were 
made using DMSO. Test solutions were made by adding stock solutions to growth medium. 
In all experiments DMSO control (0.1%) was included. Concentration of DMSO in test 
solutions was lower than 0.1% .  
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Figure 2.3. Central composite design face centred (CCF) with the compounds used in this project. Circles 
in the cube illustrates mixtures with high, medium or low concentration of benzo(a)pyrene (BaP), carbazole and 
2,5-dimethylphenol (DMP). The design includes eight mixtures from the full factorial design, represented by the 
corners of the cube, six axial points positioned on the face of the cube and a triplicate centre point, resulting in 
total 17 mixtures.  
 
Table 2.1. Ternary mixtures generated using CCF design combining high, medium and low concentrations 
of 2,5-dimethylphenol (DMP), carbazole and benzo(a)pyrene (BaP). In each individual experiment a DMSO 
control (0.1%) was included.  
Mixture 
Concentration (mg/mL) 
% DMSO 
DMP Carbazole BaP 
1 1.2E-05 1.7E-06 1.0E-07 0.06 
2 1.8E-02 1.7E-06 1.0E-07 0.07 
3 1.2E-05 1.2E-03 1.0E-07 0.06 
4 1.8E-02 1.2E-03 1.0E-07 0.06 
5 1.2E-05 1.7E-06 1.3E-04 0.07 
6 1.8E-02 1.7E-06 1.3E-04 0.08 
7 1.2E-05 1.2E-03 1.3E-04 0.07 
8 1.8E-02 1.2E-03 1.3E-04 0.07 
9 1.2E-05 5.9E-04 6.3E-05 0.07 
10 1.8E-02 5.9E-04 6.3E-05 0.08 
11 9.2E-03 1.7E-06 6.3E-05 0.04 
12 9.2E-03 1.2E-03 6.3E-05 0.04 
13 9.2E-03 5.9E-04 1.0E-07 0.08 
14 9.2E-03 5.9E-04 1.3E-04 0.09 
15 9.2E-03 5.9E-04 6.3E-05 0.07 
16 9.2E-03 5.9E-04 6.3E-05 0.07 
17 9.2E-03 5.9E-04 6.3E-05 0.07 
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2.8 PLS regression 
Results from experiments using experimental design can be analysed by projection techniques 
(Esbensen, 2000). In this master project, PLS is used. It is a regression tool, derived from 
MLR.  The latter is sufficient as long as the x-variables are fairly few and uncorrelated. Data 
sets were x-variables are co-linear, noisy and numerous can be analysed with PLS. Modelling 
several responses simultaneously is also possible with PLS (Wold et al., 2001). In this project, 
the correlation between the x-matrix (the concentration of the compounds) and the y-matrix 
(the measured EROD activity) is found by using PLS regression (Kettaneh-Wold, 1992): 
 
                                                                          (2.4) 
 
A dataset analysed by PLS has two matrices, X and Y with N×K and N×M dimensions, 
respectively. Basic assumption of PLS regression is that the studied response is influenced by 
fewer underlying variables. The PLS regression model identifies these new variables called 
X-scores (ta) which are estimates of latent variables (LVs). The X-scores predicts Y and 
models X and are linear combinations of the original variable (Xk) and the coefficients 
weights (Wka
*
) for all observations (i): 
 
    ∑    
                                                                     (2.5) 
 
The estimates of LVs are few and orthogonal. The PLS regression model determines a new 
set of scores for the observations, t and u, corresponding to x- and y-values, respectively. The 
PLS regression weights are interpretations of these score, describing how the X-matrix and Y-
matrix combine. The weights tell which variables are important for the response. Weight, 
scrores and loadings for both matrices are determined by the PLS algorithm. The estimates of 
LVs explains as much of the information in the y-response as possible, forming a new 
coordinate system, Fig 2.4. The number of estimated LVs in a model depends on predictive 
significance of each of the X-scores (Wold et al., 2001).  
 
With good models the X-scores are good approximations of the X-matrix when multiplied 
with the loading vectors (Pak), and X-residuals (eia) are small: 
 
    ∑                                                                        (2.6) 
 
The residuals for the x-matrix are the parts of the original data that is not used to generate the 
model. The x-matrix residuals are useful for identifying outliers which do not fit the model 
and points that deviate. X-scores are good predictors of the Y-matrix when combined with Y-
loadings (ca). Y-residuals (fim) are small with good models: 
 
    ∑                                                                         (2.7.) 
 
This can also be written: 
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    ∑    ∑    
 
                                                       (2.8) 
Since X-scores are derived from coefficients weights and original variables.  
 
The PLS regression coefficients (bmk) are equal to: 
 
    ∑       
 
                                                                       (2.9) 
 
Prediction of y-values can hence be performed using the original x-variables and their PLS 
regression coefficients: 
 
    ∑                                                                               (2.10) 
 
The equation for a PLS model with two x-variables (x1 and x2) shows the relationship 
between original x-variables, interaction terms and PLS regression coefficients (Brakstad, 
1992): 
 
                         
       
                             (2.11) 
 
If the relationship between the two predictor variables and the response is a linear 
relationship, then b11 and b22 is close to zero. If the relationship is quadratic these coefficients 
will be different from zero (Brakstad, 1992). 
 
Figure 2.4. Geometric representation of PLS analyses. The x-matrix and y-matrix is visualized as points in 
the multidimensional space defined by the coordinate system. The PLS model is seen as new latent variables 
(LV) estimates. Number of LV estimates depends in predictive significance and determines number of 
dimensions of the hyper plane. Observations in the original matrices are given new coordinates in relation to the 
LV estimates (Wold et al., 2001; Umetrics, 2003). 
 
Main contributors to the response and interactions between variables in a PLS model are 
visualized in a coefficient plots. The size of a coefficient represents the change in response as 
the factor is varied from zero to high. Other factors are kept at average values. The 
coefficients are generally scaled and centred. Contour plots or response surface plots show 
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predicted interaction between compounds based on the model.  The observed predicted 
interaction is only valid for the concentration range tested (Umetrics, 2003).  
 
2.8.1 Validating PLS models 
Values of explained, R
2
, and predicted, Q
2
, variation are good estimates when evaluating PLS 
models (Lundstedt et al., 1998). How much of the total variation in the y-response the model 
explains is expressed as R
2
:  
 
                                                                                        (2.12) 
 
SS is the sum of squares of total variation in a response corrected for the mean. Total SS 
include variation resulting from the regression model (SSreg) and variation resulting from the 
residuals (SSresid). A high degree of explained variance produces small residuals and larger R
2
 
(Lundstedt et al., 1998).  
 
The fraction of total variation of the response that can be predicted by the model, Q
2
, is 
obtained after cross validation by excluding about one sixth of the observations from the 
dataset and fitting the model using the remaining data. The excluded observations are 
predicted by the model generated with the remaining data. This is performed once for all 
observations. Deviation between predicted and observed values is calculated and squared 
deviations for all observations are summarized yielding predicted residual sum of squares 
(PRESS). Predicted variance can be written as: 
 
                                                                                      (2.13) 
 
A good biological model have R
2 
> 0.7 and Q
2
 > 0.4 (Lundstedt et al., 1998).  
 
The model used in this project was validated with respect to R
2
, adjusted R
2
 and Q
2
, and also 
by considering plots showing normal probability of the residuals and observed versus 
predicted EROD activity. 
 
Adjusted R
2
 is considered when non-significant terms are removed from the model. When 
additional terms are added to the model they can be given an estimated coefficient of zero, 
which will not change or slightly increase R
2
. Adjusted R
2
 considers if added terms contribute 
to explanatory power of the model and is calculated using degrees of freedom. Adjusted R
2
 
are less or equal to R
2
 (Erik Johansson pers. comm).   
 
Normal probability of the residuals can be used to identify outliers and to assess normality of 
the residuals. The plot is generated by plotting cumulative probability against the standardized 
residuals, if the latter are normally distributed the curve is s-shaped. The y-axis is adjusted so 
that the s-curve formes a straight line describing the normal distribution (Lundstedt et al., 
1998). If the residuals are not randomly distributed, systematic variation is present in the data 
which has not been included in the model. 
2 Materials and methods 
31 
 
 
Observed versus predicted plots of observations illustrates how a model predicts observations, 
and are generally sufficient to evaluate the predictive power of a model (Wold, 1996). In a 
good model observations are positioned close to the regression line. Plots showing values for 
observed versus predicted observations and normal probability can be used together with the 
replicate plot to detect outliers (Umetrics, 2003). 
 
Statistical significance of a model is illustrated in the ANOVA plot. Total variation (SS) is 
sum of variation due to the regression model (SSregr) and variation due to the residuals 
(SSresid): 
 
                                                                                     (2.14) 
 
The SSresid can be further divided into sum of squares of lack of fit (SSlof) and sum of squares 
of pure experimental error (SSpe): 
 
                                                                                       (2.15) 
 
The SSregr and the SSresid is compared in the ANOVA plot compares. Models are significant at 
the chosen probability level (usually P = 0.05) if the standard deviation of SSregr is larger than 
the standard deviation of SSresid multiplied with by the square of the critical F (RSD*√Fcrit) 
(Lundstedt et al., 1998). 
 
The model used in this project had a significant lack of fit.  For this model it was considered 
irrelevant since a good reproducibility, Fig. 3.9, can result in an artificial lack of fit (Erik 
Johanssen, Umetrics). Observed versus predicted plot, Fig. 3.12, illustrates that the model has 
good predictive power.  
 
 
2.9 Statistical tests 
Results from cytotoxicity testing of mixtures and EROD activity for all three individual 
compounds were tested for statistical significance. This was performed using SigmaPlot 
12.0.1 and One Way ANOVA with Holm-Sidak post hoc test, with p > 0.005. Calculations 
were performed in Microsoft Excel 2010 for Windows 2010.  
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3 RESULTS 
3.1 MTT cytotoxicity assay 
Absorbance was measured for a range of cell concentrations in order to determine the linear 
area of formazan formation as a function of cell concentration. Results are illustrated in 
Figure 3.1, and are presented as absorbance at 550 nm as a function of cell concentrations. 
Raw data for absorbance is presented in Appendix 2. 
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Figure 3.1. Absorbance (550 nm) as function of cell concentration (cells/mL). Independent experiments are 
marked with different symbols and are average values ± standard deviation, n=5-6. The graph is based on 
average absorbance at each of the cell concentrations tested, and is a sigmoid four parametric logistic curve, 
R
2
=0.99.  
 
 
Fig 3.1 indicates that the linear area of formazan formation was from zero to approximately 
200 000 cells/mL, with increasing standard deviation as cell concentration increased.  
 
Cytotoxicity was determined by exposing a cell concentration of 75 000 cells/mL to a 
concentration range of the compounds, or to the mixtures. Results are presented as per cent 
cell survival, DMSO control is 100% cell survival. Cytotoxicity of DMP, carbazole and BaP 
is illustrated in Fig. 3.2, 3.3 and 3.4, respectively. Highest non-cytotoxic concentration for 
DMP is approximately 0.02 mg/mL, and for BaP approximately 10
-4 
mg/mL. Carbazole has 
no apparent cytotoxic effect on PLHC-1 cells as evaluated with MTT assay.  
 
Cytotoxicity of ternary mixtures is presented in Figure 3.5. The ternary mixtures have no 
apparent cytotoxic effects in PLHC-1. Two thirds of mixtures resulted in significant higher 
cell survival compared to DMSO control, mixtures 5, 6, 7, 8, 9, 10, 12, 13, 14, 16, 17. Cells 
exposed to mixtures 1, 4, 12 and 15 showed no difference in cell survival compared to DMSO 
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control. Mixtures 2 and 3 produced significant induced cell survival only in one replicate. 
Concentrations of compounds in the mixtures are presented in Table 2.1. 
 
Raw data and per cent cell survival are presented in Appendix 2.  
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Figure 3.2. Cell survival in PLHC-1 cells presented as per cent of DMSO control after exposure to 2,5-
dimethylphenol (1.2×10
-1 – 1.2×10-5  mg/mL). Independent experiments are marked with different symbols and 
are average values of cell survival relative to average cell survival for DMSO control ± standard deviation, n=5-
6. The dotted line is DMSO control which is 100% cell survival. The graph is based on average cell survival at 
each concentration tested, and is a sigmoid four parametric logistic curve with R
2
=0.96 
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Figure 3.3. Cell survival in PLHC-1 cells presented as per cent of DMSO control after exposure to 
carbazole (1.7×10
-3 – 1.7×10-7 mg/mL). Independent experiments are marked with different symbols and are 
average values of cell survival relative to average control values ± standard deviation, n=5-6. Control is 100% 
and indicated by the dotted line. The graph is based on average cell survival at each concentration tested, and is a 
sigmoid four parametric curve, R
2
=0.013.  
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Figure 3.4. Cell survival in PLHC-1 cells presented as percent of DMSO control after exposure to 
benzo(a)pyrene (2.5×10
-3 – 2.5×10-7  mg/mL). The x-axis is logarithmic. Independent experiments are marked 
with different symbols, and are average values of cell survival related to average control values ± standard 
deviation, n=5-6. Control is 100% and indicated by the dotted line. The graph is based on average cell survival at 
each concentration tested, and is a sigmoid four parametric curve, R
2
=0.72.  
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Figure 3.5. Cell survival in PLHC-1 cells presented as per cent of DMSO control after exposure to ternary 
mixtures. Two independent experiments were performed and are indicated in grey and black. Bars are average 
values of cell survival in relation to average cell survival in DMSO control ± standard deviation, n=5-6. The 
dotted line is DMSO control which is 100% cell survival. Mixtures resulting in significant higher per cent cell 
survival compared to average DMSO control are indicated with asterisk. Significance were tested with One Way 
ANOVA using Holm-Sidak post hoc test, α=0.05 and p<0.001.  
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3.2 EROD assay 
Results are presented as average values of three parallel samples as pmol product generated 
per minute per mg protein.  
 
3.2.1 Concentration effect curves  
Concentration-effect curves for DMP, carbazole and BaP are presented in Figure 3.6, 3.7 and 
3.8, respectively. Raw data are presented in Appendix 3. 
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Figure 3.6. EROD activity (pmol resorufin/min/mg protein) in PLHC-1 after exposure to 2,5-
dimethylphenol (1.8×10
-2
 – 1.2×10-5 mg/mL). Independent experiments are indicated with different markers 
and each point is average values ± standard deviation, n=2-3. None of the concentrations tested were 
significantly different from their respective DMSO control as tested with One Way ANOVA, α=0.05. The graph 
is based on average EROD activity at each concentration tested, n=3-4, and is exponential rise to maximum, 
single, three parametric curve, R
2
=0.69. Average DMSO control is indicated with the dotted line. 
 
 
Exposure of PLHC-1 to DMP caused overall non-significant reduced EROD activity 
compared to DMSO control. Variation was greater for some concentrations. Overall induced 
EROD activity was seen for carbazole, significant only for one replicate at the highest 
concentration tested, 1.2×10
-3
 mg/mL. Concentration-effect curve of EROD activity in 
PLHC-1 after exposure to BaP was bell shaped. Three concentrations showed significant 
induced EROD activity compared to respective DMSO control in all replicates. Highest 
activity was seen in cells exposed to 1.3×10
-4
 mg/mL BaP.  
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Figure 3.7. EROD activity in PLHC-1 presented as picomol resorufin per minute per mg protein (pmol 
resorufin/min/mg protein) after exposure to carbazole (1.2×10
-3
 – 1.7×10-6 mg/mL). Independent 
experiments are indicated with different markers and are average values ± standard deviation, n=3. One exposure 
group was found to be significant different from its respective DMSO control as tested with One Way Anova 
and Holm-Sidak post hoc test, α=0.05, p=0.005. This is indicated with an asterisk. The graph is based on average 
EROD activity at each concentration tested, n=4, and is exponential growth, single, three parametric, R
2
=0.46.  
Average DMSO control is indicated with the dotted line. 
Benzo(a)pyrene
(mg/mL)
10-6 10-5 10-4 10-3 10-2
E
R
O
D
 a
c
ti
v
it
y
 
(p
m
o
l 
re
s
o
ru
fi
n
/m
in
/m
g
 p
ro
te
in
)
-4000
-2000
0
2000
4000
6000
8000
10000
*
 
*
*
 
 
Figure 3.8. EROD activity in PLHC-1 presented as picomol resorufin per minute per mg protein (pmol 
resorufin/min/mg protein) after exposure to benzo(a)pyrene (2.5×10
-3
 – 2.5×10-6 mg/mL). The x-axis is 
logarithmic. Independent experiments are indicated with different markers and each point is average values ± 
standard deviation, n=2-3. Three exposure groups were significant different from their respective DMSO control 
in all experiments as tested with One Way Anova and Holm-Sidak post hoc test, α=0.05, p=<0.001. These are 
indicated with asterisks. The graph is based on average EROD activity at each concentration tested, and is a peak 
log normal four parametric curve, R
2
=0.98.  Average DMSO control is indicated with the dotted line.  
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3.2.2 Ternary mixtures and the PLS model 
Five or six independent experiments were performed to determine catalytic EROD activity in 
PLHC-1 for the 17 ternary mixtures. The results were evaluated in excel and three replicates 
were used in PLS analyses using Modde 7.0 (Umetrics, Umeå, Sweden). Data on the PLS 
model are presented in Appendix. Replicates not included in the model are illustrated in 
column plots in Appendix 3, with raw data for the included replicates. The 17 mixtures were 
analysed in three groups; 1-6, 7-12 and 13-17, always including DMSO control (0.1%) with 
each analysis.  
 
The model used was obtained after initially including all squared, crossed and interacting 
terms and then removing non-significant terms consecutively judging improvement by 
considering adjusted R
2
. Appendix 5 includes tabulated values for R
2
, adjusted R
2
 and Q
2
, 
together with number of LVs for each model investigated. The best model obtained excluded 
the two non-significant interactions, DMP×BaP and BaP×carbazole. The model have two 
LVs, R
2
 = 0.91, adjusted R
2
 = 0.89 and Q2 = 0.88.  
 
A replicate plot is presented in Fig. 3.9. Variation between replicates is different for mixtures, 
but overall low. Lowest variation is seen for mixture 5, 7, 8, 11, while 1, 3, 4, 6, 12 and 14 
show greater variation.  
 
 
Figure 3.9. Replicate plot showing EROD activity (pmol resorufin/min/mg protein) in PLHC-1 after 
exposure ternary mixtures of high, low and medium concentrations of 2,5-dimethylphenol, carbazole and 
benzo(a)pyrene. Greater distance between markers indicates greater variation. Numbered markers are parallels 
in independent experiments: 1-17 the first individual experiment, 18-34 number two and 35-51 number three.  
Mixture 15 is mixtures for centre point. Composition of the mixtures is presented in Table 2.1. 
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Normal probability plot of the residuals is presented in Fig. 3.10 and Fig. 3.11 shows 
observed versus predicted values for EROD activity. Parallels 15 and 49 diverge from the line 
in Fig. 3.10 and 3.11 and are slightly higher than rest of the parallel samples for the center 
points in the replicate plot. These parallels were considered to be outliers and removed from 
the data set.  
 
Figure 3.10. Normal probability plot for the model generated to study combined effects in mixtures with 
2,5-dimethylphenol, carbazole and benzo(a)pyrene.  
 
 
Figure 3.11. Predicted versus measured EROD activity (pmol/min/mg protein) using the best obtained 
model generated to study combined effect in ternary mixture with 2,5-dimethylphenol, carbazole and 
benzo(a)pyrene. Number 1-17 are parallel samples in the first individual experiment, 18-34 parallel samples in 
the second, and 35-51 in the third.  
 
The new model have R
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 = 0.93, adjusted R
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 = 0.92 and Q
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 = 0.90 and two LVs. The first LV 
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confidence interval (Appendix 5). Lowest EROD activity after exposure to ternary mixtures 
was negative, -1 337 pmol resorufin/min/mg protein and caused by mixture 2, second 
replicate (19). Mixture 2 has high concentration of DMP and low of both carbazole and BaP 
(Table 2.1). Highest EROD activity, 9598 pmol resorufin/min/mg protein, was induced by 
mixture 14, first replicate (14). Mixture 14 has medium concentration of DMP and carbazole 
and high concentration of BaP. Predicted versus measured plot of values for EROD activity 
for the model used in this project is presented in Fig. 3.12.  
 
 
Figure 3.12. Predicted versus measured EROD activity (pmol/min/mg protein) from the PLS-model 
generated to study combined effects in ternary mixture 2,5-dimethylphenol, carbazole and 
benzo(a)pyrene. Number 1-17 are parallel samples in the first individual experiment, 18-34 parallel samples in 
the second, and 35-51 in the third.  
 
 
Fig 3.13 is the coefficient plot for the PLS model. The model has seven PLS regression 
coefficients. The linear terms BaP (p<0.001) and carbazole (p=0.006) show a significant 
positive effect on EROD activity. The quadratic terms DMP
2
, Car
2
 and BaP
2
 (p<0.001), 
together with the interaction term DMP×Car (p=0.003) show a significant negative effect on 
EROD activity.  The linear term DMP (p=0.15) show non-significant negative effect on 
EROD activity. 
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Figure 3.13. Scaled and centred PLS regression coefficients for a model of EROD activity in PLHC-1 
exposed to ternary mixtures with 2,5-dimethylphenol (DMP), carbazole (car), and benzo(a)pyrene (BaP). 
Significant terms are the linear terms car and BaP, quadratic terms DMP
2
, car
2
, BaP
2
, and also the interaction 
term DMP×Car.  
 
 
The PLS regression model predicted combined effect of co-exposure to the compounds, 
visualized in 4D contour plots showing EROD activity after co-exposure of PLHC-1 to two 
compounds in three plots where the third compound is at low, medium and high 
concentration, from left to right in the figures. Predicted combined effect of BaP×Carbazole, 
DMP×BaP and carbazole×DMP are presented in Fig. 3.14, 3.15 and 3.16, respectively.  
 
Fig 3.14 illustrates that both BaP and carbazole caused increased EROD activity when present 
in ternary mixtures. Co-exposure to the compounds caused higher EROD activity compared to 
single exposure. Co-exposure to BaP and DMP in ternary mixtures, Fig. 3.15, caused 
increased EROD activity for increasing concentrations of BaP, while DMP reduces EROD 
activity at higher concentrations. Fig. 3.16 shows that EROD activity was highest when both 
DMP and carbazole were present at medium concentrations. 
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Figure 3.14. EROD activity (pmol resorufin/min/mg protein) predicted for co-exposure to carbazole and 
benzo(a)pyrene (BaP) (mg/mL) by a PLS model obtained after measuring EROD activity in PLHC-1 after 
exposure to ternary mixtures. DMP are set low (1.2×10
-5
 mg/mL), medium (9.3×10
-3
 mg/mL) and high 
(1.8×10
-2
 mg/mL) concentration from left to right.  
 
 
 
 
Figure 3.15. EROD activity (pmol resorufin/min/mg protein) predicted for co-exposure to 2,5-
dimethylphenol (DMP) and benzo(a)pyrene (BaP) (mg/mL) by a PLS model obtained after measuring 
EROD activity in PLHC-1 after exposure to ternary mixtures. Carbazole are set to low (1.7×10
-6
 mg/mL), 
medium (5.9×10
-4
 mg/mL) and high (1.2×10
-3
 mg/mL) concentration from left to right.  
 
 
 
 
Figure 3.16. EROD activity (pmol resorufin/min/mg protein) predicted for co- exposure tocarbazole and 
2,5-dimethylphenol (DMP) (mg/mL) by a PLS model obtained after measuring EROD activity in PLHC-1 
after exposure to ternary mixtures. BaP are set to low (10
-7
 mg/mL), medium (6.3 × 10
-5
) and high (1.3×10
-4
 
mg/mL) concentration.   
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3.3 Genotoxicity of the ternary mixtures 
DNA damage is presented as RNSB/kb. Extent of DNA damage was assessed by separating 
DNA on gel according to size. Median migration distance can be used to find RNSB/kb. 
Results from two independent experiments each with three parallels for the mixtures are 
illustrated in a column plot, Fig. 3.17. Calculated values are presented in Appendix 6, together 
with an illustration of the raw data. Raw data is not presented due to space limitations.  
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Figure 3.17. Relative number of DNA double strand breaks per kilo base pair (RNSB/kb) in PLHC-1 after 
exposure to three ternary mixtures, 7, 9 and 14. Two independent experiments were run with three parallels 
for each mixture. Independent experiments are indicated in black and grey and the parallel samples are presented 
as columns. Concentration of 2,5-dimethylphenol, carbazole and benzo(a)pyrene in the mixtures are presented in 
Table 2.1.  
 
 
 
Fig. 3.17 shows substantial variation in in RNSB/kb. Analyses of DNA DSB were only 
performed with mixture 7, 9 and 14.  
4 Discussion 
45 
 
4 DISCUSSION 
Results are discussed here in the same order as they are presented in Chapter 3. Cell 
concentration used in the MTT assay and cytotoxicity of single compounds and mixtures are 
discussed, as well as concentration-effect curves for EROD activity of single compounds. 
Optimising of the EROD protocol and confounding factors of EROD activity in vitro and in 
vivo are discussed. The statistical design and concentrations included in the design are 
discussed and the regression model is evaluated together with in vitro studies. Ternary 
mixtures are evaluated with respect to induced EROD activity and predicted interaction based 
on the regression model. Genotoxicity of the ternary mixtures is discussed before further work 
is suggested.  
 
4.1 Cytotoxicity 
4.1.1 Cell concentration  
Cytotoxicity is more precisely determined using cell concentration within the linear area of 
formazan formation. In this master project the linear area was from zero to approximately 
200 000 cells/mL for PLHC-1, Fig. 3.1. Higher cell concentrations showed increasing 
variation. A cell concentration of 75 000 cells/mL was used in further cytotoxicity testing. 
Cell concentration is the concentration initially seeded, determined by counting cells in grids 
on a haemocytometer.  
 
The concentration determined in the MTT assay is assumed to be highly subjective since 
concentration was determined by counting cells manually. It was observed that cell 
concentration was dependent to considerable extent on the individual performing the 
experiment and also the cell line. The intention of the procedure is to identify optimal seeding 
density for further cytotoxicity testing, making consistent counting between experiments 
important. Non-consistent counting and a non-homogenous cell suspension can result in 
variability between experiments. The subjectivity of the determined cell concentration is 
suggested to be a problem if cell concentrations are compared between researchers.  
 
Experiments with living systems are subject to variation, also highly controlled laboratory 
experiments. Non-homogeneous cell suspension of PLHC-1 was observed since the cells have 
a tendency of forming cell aggregates. Cell aggregates of PLHC-1 require vigorous shaking to 
disperse. Such treatment is assumed to significantly decrease cell survival. Homogeneity of 
cell suspension was fairly maintained by gently turning the tube containing cell suspension 
upside down a few times before distributing aliquots onto plates.    
 
4.1.2 Cytotoxicity of single compounds 
A concentration dependent increase in cytotoxicity in PLHC-1 exposed to DMP was observed 
from approximately 0.02 mg/mL, Fig. 3.2. Cells exposed to lower concentrations showed 
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slightly reduced cell survival compared to DMSO control. Results were variable between 
parallel samples and repeated experiments. Phenolic fraction of produced water was important 
contributor to acute toxicity determined by using the Microtox test (Phosphobacterium 
phosphoreum) (Johnsen et al., 1994). Lethality of APs to shrimp and salmon was seen to 
increase with increasing molecular weight and Kow of compounds, with structure and position 
of the substituted carbon chain affecting toxicity. Concentration of C4-AP causing 50% 
reduction in survival after 96 hours exposure was found to be 1.3×10
-3
 and 7.4×10
-4
 mg/mL 
for shrimp and salmon, respectively(Mcleese et al., 1981). Cytotoxicity of p-methyl phenol to 
a rainbow trout gonadal cell line (RTG-2) measured as inability to attach to growth surface 
were 2,85 mg/mL (Bols et al., 1985).  
 
Defined cytotoxic effect was not seen in PLHC-1 after exposure to carbazole at the 
concentration range tested, Fig. 3.3. Variability between parallels and replicates was 
substantial. Neutral red assay with a rainbow trout liver cell line (RTL-W1) assessing 
cytotoxicity of carbazole showed no cytotoxic effect of concentrations as high as 0.01 mg/mL 
(Hinger et al., 2011), which is higher than the concentrations included in this master project. 
Studies with bacteria conclude that carbazole had no immediate toxic effect in the cells up to 
2 mg/mL (Castorena et al., 2006). A sharp decline in neutral red uptake were seen for the 
NPAHs and azaarenes assessed by Jung and co-workers (2001) at concentrations 
approximately 15 times higher than concentrations tested in this master project.  
 
Slight cytotoxicity was observed in PLHC-1 for BaP concentrations higher than 
approximately 10
-4
 mg/mL, Fig. 3.4. Variability between parallels and replicates was larger 
for certain concentrations. Previous studies of BaP using PLHC-1 and the neutral red assay 
with 24 hours incubation showed no cytotoxic effect for concentrations lower than 0.03 
mg/mL (Fent and Bätscher, 2000). No observed effect concentrations obtained with Microtox 
test (Vibrio fischeri) for BaP was 2.3×10
-3
 and 0.019 mg/mL for 5 and 30 minutes exposure, 
respectively (Macken et al., 2008).  
  
Variation between replicates and parallels in MTT cytotoxicity assay is suggested to be 
caused by non-homogenous cell suspension or variation in actual compound concentration. 
Significant loss of carbazole from solution is reported (Hinger et al., 2011). Loss of carbazole 
from test solutions could have resulted in variable exposure conditions in all assays performed 
in this master project. Concentration of compounds in test solution was not measured.  
 
4.1.3 Cytotoxicity of ternary mixtures 
Cytotoxic effects were not observed for the mixtures, Fig. 3.5, and approximately two thirds 
of the mixtures significantly induced cell survival. Induced cell survival after exposure to 
potentially harmful compounds can be due to hormesis. Maximum stimulatory response if 
hormesis is present is usually modest, at maximum 30 to 60%. Hormosis can be caused by 
direct stimulation or overcompensation. Proposed mechanisms for hormesis are numerous 
(Calabrese, 2008). A general mechanism is activated protective enzymatic pathways (Klaunig 
4 Discussion 
47 
 
and Kamendulis, 2008). True hormetic dose response cannot be established if high-dose 
inhibition is not detected (Calabrese, 2008).  
 
4.2 EROD activity of single compounds, optimising the EROD protocol and 
confounding factors 
Catalytic EROD activity is previously used as an approximation of CYP 1A activity in 
PLHC-1 and is assumed to be sufficient as a representation of available CYP 1A activity 
(Hahn et al., 1993).  
 
4.2.1 Concentration effect curves  
Overall DMP caused non-significant reduced EROD activity in PLHC-1 compared to DMSO, 
Fig. 3.6. Lower concentrations of DMP have higher variability compared to higher 
concentrations. 
 
Long-chain APs are known to inhibit CYP 1A activity (Arukwe et al., 1997). Several 
mechanisms for interaction between AhR pathway and oestrogen receptor pathway are 
suggested (Brosens and Parker, 2003; Bemanian et al., 2004; Matthews and Gustafsson, 
2006). Long-chain APs exhibit oestrogenic properties (Routledge and Sumpter, 1997; Arukwe 
et al., 2001) and likely inhibition of CYP 1A is via oestrogen receptor pathway (Andersson 
and Forlin, 1992). Oestrogenicity is assumed to require three or more carbon atoms in the 
hydrocarbon chain. Potent oestrogenic APs have the carbon chain placed in para position on 
an otherwise unhindered phenol ring (Routledge and Sumpter, 1997). Structure of DMP, Fig. 
1.2, is suggested not to be consistent with oestrogenic activity.  
 
One and four weeks exposure of Atlantic cod to a mixture of C4 to C7 APs resulted in dose 
dependent increase in CYP 1A content only in male fish and dose dependent increase in 
EROD activity only in female fish only after one week exposure (Hasselberg et al., 2004b). In 
cod orally exposed to the same mixture of C4 to C7 APs for 20 weeks, transcription of CYP 
1A was up regulated (Lie et al., 2009). A small non-significant increase in cytotoxicity was 
observed for the concentration range of DMP included in the design. 
 
Exposing PLHC-1 to a concentration range of carbazole induced EROD activity slightly. 
Enhanced activity was significant compared to DMSO control at highest concentration only 
for one replicate, Fig. 3.7. Heterocyclic compounds are suggested to contribute to increased 
CYP 1A activity observed for contaminated sediments in vitro (Brack and Schirmer, 2003). 
Azaarenes and NPAHs caused bell shaped induction of EROD activity and sigmoidal 
induction of CYP 1A protein. Potency of inducing EROD activity (–log EC50) of NPAHs and 
azaarenes correlated with log Kow, and Lmax, respectively.  Maximum enhanced EROD 
activity induced by these compounds was generally induced by concentrations between 10
-6
 
and 10
-5
 M (Jung et al., 2001). This approximately corresponds to medium and high 
concentration of carbazole included in this master project  
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Molecular requirements describing relative affinity for AhR include electron acceptor 
capability, polarizability, planarity, steric fit and hydrophobicity (Mekenyan et al., 1996). 
Steric parameters are suggested more important for PAHs (Johnels et al., 1989), while for 
polychlorinated biphenyls (PCBs) co-planarity is important for steric fit and net polariziability 
for binding affinity. Polarizability should preferentially be distributed about a molecular 
length of 10.5 Å (McKinney and Singh, 1981). Position of nitration in nitrated compounds 
can affect polarizability and affinity for AhR (Lofroth et al., 1984). Carbazole is planar (Fig 
1.3.) and has intermediate lipophilicity, log Kow of 3.28 (Lassen and Carlsen, 1999). Nitrogen 
is a strongly electronegative atom (Solomons and Fryhle, 2004) and could result in 
polarization perpendicular to the length of the molecule. Common structural feature of PAHs 
with high AhR inducing potency is a four- to six-ring system containing fluoranthene or 
phenanthrene structures with an exposed bay region. Two and three ring un-substituted PAHs 
are generally not potent AhR inducers (Barron et al., 2004). And also for NSO-HETs the four 
and five ring compounds are suggested to be more potent compared to compounds with three 
rings at inducing EROD activity (Jung et al., 2001).  
 
Inconsistency is seen for AhR affinity and potency of inducing CYP 1A activity (Piskorska-
Pliszczynska et al., 1986; Hinger et al., 2011). Carbazole was showed to have affinity for the 
AhR in the DR-CALUX assay with H4IIE at concentrations of 0.167 mg/mL, but enhanced 
CYP 1A activity was not detected (Hinger et al., 2011).  
 
Studies evaluating the EROD inducing potential of carbazole at concentrations relevant for 
produced water are not found. Carbazole is present in produced water and suggested to be a 
contributor to EROD inducing potential of produced water. Since carbazole is shown to have 
affinity for AhR (Hinger et al., 2011) it can be expected to have potential to modify CYP 1A 
activity. The affinity of carbazole for AhR was seen at concentrations higher than what is 
assumed to be relevant for produced water.    
 
Competitive inhibition of EROD activity by NPAHs and azaarenes is seen (Jung et al., 2001) 
and cannot be excluded as the cause for the observed low EROD activity based on the results 
obtained in this master project. 
 
Variability between parallels and individual experiments observed can be due to low 
efficiency and low potency of carbazole at inducing EROD activity as suggested by Hinger 
and co-workers (2011). Per cent relative standard deviation (RSD%) is a measure of 
experimental error. After exposure of PLHC-1 to BaP, RSD% for average values of EROD 
activity was ±35%. This is similar to RSD% obtained by Hinger and co-workers (2011).  
Experimental error is suggested not to be the cause for the observed variability between 
parallels and experiments in this master project. Significant loss of chemical reported for 
carbazole (Hinger et al., 2011) could contribute to variable exposure situations and variation 
observed. Hinger and co-workers suggests sorption or precipitation as possible causes for loss 
of chemical. Volatilization was also suggested, but was excluded since sealing the plates with 
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membrane did not prevent loss. Chemical reactions with other compounds present in test 
solution might also cause loss of chemical.   
 
Low EROD activity measured after exposure to carbazole can be caused by sub-optimal 
exposure time. Exposure for 8 hours appears optimal for induction by BaP at the 
concentrations tested (results presented in this master project and Smeets et al. 2001), but can 
be different for carbazole. Co-exposure with DMP and BaP (Chapter 4.4) resulted in 
significant induction of EROD activity by carbazole.  
 
Exposure of PLHC-1 to BaP produced a bell shaped concentration-effect curve, Fig. 3.8. 
Three of the concentrations tested resulted in significant increased EROD activity compared 
to DMSO control. Low and high concentration of BaP did not significantly alter EROD 
activity compared to control. The non-significantly increased cytotoxicity seen for highest 
exposure concentration of BaP is not assumed to reduce EROD activity.    
 
Enhanced CYP 1A protein concentration and activity are previously seen for BaP (Smeets et 
al., 1999; Fent and Bätscher, 2000). Concentration-effect curves are bell shaped for EROD 
activity and sigmoidal for protein. Reduction in EROD activity at higher exposure 
concentrations is suggested to be caused by inhibition of catalytic activity by residual 
compound present in cells during activity assessment (Hahn et al., 1993; Brüschweiler et al., 
1996; Hahn et al., 1996; Smeets et al., 1999; Fent and Bätscher, 2000). Competition was 
indeed confirmed to take place at the active site of the enzyme between dibenz(a,h)antracene 
and ER (Fent and Bätscher, 2000). Uncoupling of CYP 1A catalytic cycle is not detected after 
exposure to BaP (Schlezinger et al., 1999).  
 
Induction of CYP 1A protein and activity after exposure to BaP is suggested to occur via an 
AhR independent pathway involving glycine-N-methyltransferase (GNMT) as a trans-acting 
transcription factor (Raha et al., 1995). High affinity of BaP for GNMT was observed in 14-
day-old chick embryos (Raha et al., 1999). Studies with AhR deficient mice indicate that 
sustained transactivation of CYP 1A requires AhR (Foussat et al., 1998). The tetrameric form 
of the GNMT has methyltransferase activity, while the dimeric form binds PAHs. In humans 
GNMT sequesters BaP (Parkinson and Ogilvie, 2008). 
 
4.2.2 Optimising the EROD protocol 
Protocol for determining EROD activity was modified after a protocol presented by Fent and 
Bätscher (2000), Fig. 2.1. Cells were cultivated on 24 rather than 96 well plates to obtain 
sufficient quantities of material for analysing both EROD activity and total protein. It was 
considered more exact to do both assays on the same cell material. Wells on 24 well plates 
have well area about six times larger than 96 well plates. Suspension of cell content was 
necessary to determine EROD activity and total protein on same sample material. Previous 
experience, with the rat hepatoma cell line H4IIE, has shown that mechanical harvesting is 
sufficient for lysis of cells and suspension of cell content (Renate Haldsrund, pers. comm.) 
and was included in the protocol.  
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For EROD assay about one third of the cell suspension from each well on a 24 well plate was 
transferred to wells on a 96 well plate approximately doubling cell volume compared to Fent 
and Bätscher (2000). Double amount of ER resulted in higher EROD activity suggesting that 
substrate initially was a limiting factor. Double NADPH concentration showed no effect on 
EROD activity. Exogenous NADPH was found not to be a prerequisite for EROD activity in 
PLHC-1 (Hahn et al., 1996). The concentration of NADPH as described by Fent and Bätscher 
(2000) was still included in the protocol. The need for exogenous NADPH was not studied 
due to time limitations. 
 
Harvesting was considered in two steps. First optimising involved a second freeze/thaw cycle 
of 30 to 60 minutes after adding 160 µL Tris to each well. This increased EROD activity 
suggested to be caused by more efficient lysis and detachment caused by crystals of Tris 
formed during freezing. The effect of three sequential freeze/thaw cycles was studied and was 
found to decrease EROD activity, suggested to be caused by increased degradation of 
enzyme.  
 
Effect of a lower initial seeding density was considered by seeding 70% and 50% of the 
ordinarily seeded cell content. Dense growth conditions were contemplated to have an effect 
on enzyme activity. Less dense seeding did not enhance enzyme activity and dense seeding 
conditions are suggested not to have effect on enzyme activity. 
 
Protein induction is considered to be a rapid response (Ryan and Hightower, 1994). Effect of 
shorter exposure time was studied. Temporal assessment of CYP 1A activity in PLHC-1 
indicates that time for maximal activity is dependent on exposure compound and 
concentration. Exposure of PLHC-1 to 10
-4
 mg/mL BaP produced highest EROD activity after 
eight hours (Smeets et al., 1999). Changing the exposure time to eight hours increased 
enzyme activity and was included in the protocol. The preliminary protocol was verified with 
an identical performed experiment yielding similar response in EROD activity. This protocol 
was assumed adequate and was used when determining EROD activity.  
 
The protocol presented by Jung and co-workers (2001) determines both EROD activity and 
total protein on the same plates as cells are seeded and appear as a good alternative providing 
less handling of sample by avoiding the harvesting step. Less handling is better when working 
with enzymes since enzyme activity is easily diminished. Number of steps in the deployed 
protocol can be reduced by assessing the requisite for NADPH, and also BSA which is 
included to preserve proteins, but found not to be of importance for EROD activity (Hahn et 
al., 1996).  
 
4.2.3 Confounding factors 
Catalytic activity of CYP 1A is regarded as both a biomarker of exposure to and effect of 
compounds (van der Oost et al., 2003). Induced CYP 1A activity is a transient, short time 
response and do not necessarily equate harmful effects in vivo. In vivo exposure to AhR 
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agonists are modulated by a range of confounding factors as age, sex, reproductive status and 
nutritional status (van der Oost et al., 2003; Hylland et al., 2009). 
 
Discrepancy observed between CYP 1A catalytic activity and CYP 1A protein concentration 
(Hahn et al., 1993; Brüschweiler et al., 1996; Hahn et al., 1996; Smeets et al., 1999; Fent and 
Bätscher, 2000; Jung et al., 2001), is suggested to be due to competitive inhibition (Fent and 
Bätscher, 2000) or inactivation by formation of ROS at active site (Schlezinger et al., 1999). 
Comparing potency of two PCBs to TCDD at inducing EROD activity and CYP 1A protein 
showed substantially lower EROD activity at maximum for the two PCBs, but no difference 
in CYP 1A protein (Hahn et al., 1993). Incorrect assumptions about maximum induced EROD 
activity can underestimate EROD inducing potency of compounds.  
 
Maximum EROD activity can be confounded by temporal response variations (Smeets et al. 
1999 and results presented in this project), and optimum exposure time is dependent on 
exposure concentration. Three low concentrations (10
-4
, 2.5×10
-5
 and 2.5×10
-6
 mg/mL) of 
BaP induced maximum EROD activity in five to eight hours (five, five and eight hours, 
respectively). Higher concentration induced increasing EROD activity until end of experiment 
at 48 hours (Smeets et al., 1999).  
 
Temporal assessment of EROD activity could confirm that lack of activity of low activity are 
not due to unfavourable exposure time. Measureing protein and mRNA levels of CYP 1A in 
addition to EROD activity could reveal competitive inhibition. Non-competitive enzyme 
linked immunosorbent assay (ELISA) was suggested by Brüschweiler and co-workers (1996) 
as method for assessing CYP 1A protein levels. Real time, quantitative polymerase chain 
reaction (RT-qPCR) can be used to quantify mRNA levels of CYP 1A.  
 
Modulated EROD activity is seen as a good indication of whether compounds have potential 
to interfere with biotransformation enzymes activity in vitro, and is indicated to precede 
potentially deleterious effects at higher levels of biological organization(van der Oost et al., 
2003). A clear relationship is seen for tissue contaminant load, physiological status and 
EROD activity in Atlantic cod examined over an eight year period (Hylland et al., 2009).  
 
4.3 The CCF design, the PLS model and in vitro studies 
In this project interaction between DMP, carbazole and BaP was evaluated using CCF design 
and PLS regression modelling in vitro.  
 
4.3.1 The CCF design and concentrations included 
Modde 7 was used for generating both design and regression model. In Modde it is possible to 
choose between screening and response surface modelling (RSM). Screening identifies 
important variables contributing to the measured response. Detailed modelling using quadratic 
and cubic terms is possible using RSM (Umetrics, 2003). Important contributor was assumed 
to be BaP. Interacting effects were considered interesting to investigate.  
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When selecting RSM as purpose, it is possible to choose from five different designs in 
Modde. First recommended is Central Composite Face (CCF) design, while Box Behnken is 
recommended as second. Box Behnken design has fewer mixtures compared to CCF, 15 vs. 
17, respectively, including a triplicate centre point for both, and is the economic alternative 
(Esbensen, 2000). Box Behnken design does not include experiments with all three 
compounds at high concentrations. It is important to have knowledge about interaction at high 
exposure concentrations. The preferred design alternative was CCF with three centre points. 
Centre points are included to investigate if non- linearity is present and to verify 
reproducibility (Esbensen, 2000).  
 
Concentrations included in the design were based on cytotoxicity, EROD concentration effect 
curves of single compounds and environmental concentrations. High concentration of DMP 
was set to 0.018
 
mg/mL, which were the highest non cytotoxic concentration. Low 
concentration for DMP was set to 1.2×10
-5 
mg/mL. The concentrations included for DMP are 
environmentally realistic (Appendix 4). High concentration of carbazole was set to 1.2×10
-3 
mg/mL. High concentration was set to highest possible exposure concentration limited by 
aqueous solubility. Low concentration was set to 1.7×10
-6 
mg/mL. Reports of carbazole 
concentration in produced water are not found. High concentration of BaP was set to 1.3×10
-4 
mg/mL. This concentration induced highest EROD activity of the concentrations tested (Fig. 
3.7). The high concentration chosen is within the same ranges as concentration of BaP used in 
others studies (Smeets et al., 1999; Fent and Bätscher, 2000). Low concentration was set to 
10
-7
 and is environmentally realistic (Utvik, 1999).  
 
4.3.2 The PLS model 
In this project a PLS model was used to detect interaction between compounds. Fit of a model 
is sufficiently evaluated by considering values for R
2
 and Q
2
 (Lundstedt et al., 1998). The best 
model obtained had R
2
 of 0.93 and Q
2
 of 0.90. Two non-significant interaction terms were 
removed from this model. When removing non-significant terms adjusted R
2
 was considered. 
The best obtained model had adjusted R
2
 of 0.92. Biological models are considered acceptable 
with R
2
 above 0.7 and Q
2
 above 0.4 (Lundstedt et al., 1998). Explained and predicted 
variance, R
2
 and Q
2
, for the model obtained is better than the values suggested as acceptable 
indicating good explanatory and predicative power of the model. The model has two LVs. 
 
Normal probability plot of the residuals was also used when evaluating the model. Residuals 
are variance not explained by the model (Esbensen, 2000). All points in Fig. 3.10 align along 
the regression line indicating that no important, systematic variation is excluded from the 
model.  
 
Parallels 15 and 49 were considered to be deviating and removed from the model based on the 
observed versus predicted plot, Fig. 3.11, and Fig. 3.10. Observed versus predicted plot 
illustrates the predictive power of a model and parallels should fall close to the regression line 
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for good models. This is seen in Fig. 3.12. The model was considered good based on R
2
, Q
2
 
and observed versus predicted plots. 
 
4.3.3 In vitro studies for evaluating environmental effects 
Environmental exposure of fish to produced water is assumed to involve myriads of 
compounds in various stages of degradation with varying composition between different 
locations (Utvik, 1999; Holth et al., 2008). Harmful compounds may have markedly different 
time of onset for toxic effect, some requiring long term, chronic exposure before effects are 
manifested (Calabrese, 1995). The sequential order of exposure may affect toxicity of 
compounds. Exposure of PLHC-1 to PCB 126 for 24 hours and then BaP for four hours 
increased metabolism of BaP and formation of RNA adducts compared to exposure to BaP 
singly (Smeets et al., 1999). Laboratory interaction studies can be limited by exposure 
regimes administering compounds simultaneously (Calabrese, 1995). Toxic effects observed 
in vitro can in in vivo environmental exposure be modulated by toxicokinetic factors affecting 
absorption and distribution of toxic compounds and by several natural stressors (Fent, 2001). 
Toxic effects of a compound are not manifested unless the active compound is transported to 
the site of toxic action at concentrations sufficient to produce a response over the duration of 
time required (Eaton and Gilbert, 2008).  
 
The PLHC-1 cell line is derived from a tropical fish species. Assessing effects in a cell line 
from a temperate species is considered more relevant for produced water exposure. Results 
obtained with the cell line is assumed possible to transfer to cellular mechanics in more 
temperate species, since interaction between potentially harmful compounds and biological 
systems initiates at the molecular levels. Cellular effects are assumed, to a certain degree, to 
be universal across species (Fent, 2001; Castaño et al., 2003). Since interspecies differences 
exist, it was investigated if a cod cell line was obtainable and could be used. As far as is 
known, a stable continuous cod cell line is not developed. 
 
Cells from PLHC-1 are assumed to be a good system for examining the relative CYP 1A 
inducing potency of aromatic hydrocarbons in fish (Hahn et al., 1993). Good correlation 
between toxicity in vitro and acute toxicity in vivo is observed for PLHC-1. Studies performed 
with this cell line are suggested to be a good approximation to environmental studies (Fent 
and Bätscher, 2000). The cell line is used in several studies for evaluating interaction between 
compounds (Fent and Bätscher, 2000; Jung et al., 2001). 
  
4.4 Combined action in ternary mixtures 
4.4.1 Combined action measured as EROD activity 
Catalytic EROD activity in PLHC-1 after exposure to the ternary mixtures was significantly 
induced by the potent agonist BaP, which was approximately six times more potent than 
carbazole also inducing EROD activity significantly, Fig. 3.13. Regression coefficients 
describe the relationship between variation in a set of predictor variables and variation in the 
4 Discussion 
54 
 
response in a PLS model (Esbensen, 2000). Size of the coefficients illustrates change in 
response when factors are varied from 0 to 1, while the other factors are kept at average value. 
Coefficients are considered significant when confidence intervals do not cross zero (Umetrics, 
2003). Significant enhanced EROD activity after exposure to BaP was expected based on 
single exposure (Fig. 3.8). 
 
Significant induced EROD activity caused by carbazole appear conflicting to concentration-
effect curves for EROD activity after exposure to carbazole singly (Fig. 3.7). The significant 
square terms modulating EROD activity negatively indicates non-linearity in the model. The 
one significant interaction term in the model, DMP×Carbazole, showed negative modulation 
of EROD activity. Interaction with DMP is suggested not to be the explanation of differently 
modulated EROD activity after combined exposure compared to single exposure to carbazole.  
 
Predicted co-exposure of carbazole and BaP, Fig. 3.14, showed increasing EROD activity 
with increasing concentration of carbazole. Increased EROD activity after co-exposure to BaP 
and carbazole is not large compared to exposure to the compounds singly. Maximum induced 
EROD activity after exposure to BaP and carbazole singly caused a positive change of 
approximately 6 500 and 500 pmol resorufin/min/mg protein, respectively, compared to 
DMSO control. Maximum induced EROD activity after co-exposure at low concentration of 
DMP was predicted to 7000 pmol resorufin/min/mg protein (Fig. 3.14, left plot). Binary 
mixtures of PAHs have shown additive combined effects (Fent and Bätscher, 2000). Also 
binary mixtures of PAHs with either NPAHs or azaarenes show additive combined effect 
(Jung et al., 2001). Simple similar action or simple dissimilar action can result in additive 
combined effects, which would imply either same mechanism of action or different 
mechanisms with negative correlation or no correlation of susceptibility for the assessed 
compounds (Cassee et al., 1998). Different mechanisms of EROD induction could be 
suggested for carbazole and BaP since carbazole is shown to bind AhR (Hinger et al., 2011) 
while BaP is suggested to induce EROD activity via GNMT (Raha et al., 1999). Nature of 
additive combined effect can be studied by comparing EC50 for single exposure to EC50 of 
combined exposure as was done by Fent and Bätscher (2000) and Jung and co-workers 
(2001).  
 
Reduced EROD activity was predicted at high concentrations of co-exposure, Fig. 3.14. 
Competitive inhibition has been observed for binary mixtures of PAHs (Fent and Bätscher, 
2000), NPAHs and PAHs and also for azaarenes and PAHs (Jung et al., 2001) and is 
suggested to be the cause for the predicted decrease. By suggesting competitive inhibition at 
higher concentrations it is suggested that both carbazole and BaP interacts with CYP 1A. 
Monohydroxy metabolites of carbazole have been detected in bile of rainbow trout orally fed 
olive oil containing carbazole (Hellou et al., 2002), suggesting oxidative biotransformation of 
carbazole. In bacteria carbazole is metabolized by oxidases forming monohydroxy 
metabolites (Resnick et al., 1993; Shindo et al., 2001; Waldau et al., 2009). The discrepancy 
between EROD inducing potency for carbazole singly and in the model is suggested to be 
explained by the presence of an EROD inducing metabolite formed by catalytic action of 
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CYP 1A. Induced CYP 1A by BaP could enhance formation of the suggested carbazole 
metabolite in the ternary mixtures. 
 
Carbazole was reported to inhibit EROD activity induced by a potent AhR agonist in embryo 
of killifish. The inhibition was assumed to be non-competitive based on kinetic analysis 
(Wassenberg et al., 2005). Non-competitive inhibition of enzymes occurs when substrate and 
inhibitor binds simultaneously to the enzyme at different binding sites (Berg et al., 2007). 
Enzyme inhibition can be studied by varying the substrate concentration.  
 
The discrepancy between effects of carbazole singly compared to mixed exposure can be 
studied further by adding additional mixtures to the design. Mixtures with only two 
components present could affirm that the coefficient for carbazole is due to effects of 
carbazole, and not BaP. 
 
Co-exposure to carbazole and DMP in ternary mixtures significantly inhibited EROD activity, 
Fig. 3.13, while DMP alone had a negative, non-significant effect. Negative interaction 
coefficients are suggested to be caused by either response addition with positive correlation or 
antagonism. Predicted interactions between the two compounds, Fig. 3.16, show similarity 
with isobolograms displaying antagonistic action between two compounds (Eide, 2002). 
Interaction between compounds is usually seen at high concentrations and the mechanism 
behind may be of biological or physiochemical nature. Chemical reactions between 
compounds could yield more or less toxic compounds compared to parent compound 
(Calabrese, 1995; Eide, 2002). Low concentration interaction usually is interaction in 
toxicokinetic phase (Eide, 2002). In in vitro studies either toxicokinetic interaction affecting 
biotransformation processes or chemical interaction are suggested as likely interactions and 
cause for the predicted interaction.  Adding additional mixtures to the design could also 
contribute to understanding interaction between DMP and carbazole. 
 
In all three figures predicting combined exposure, Fig. 3.14, 3.15 and 3.16, EROD activity 
was higher for medium concentrations and lower for low and high concentrations of DMP. 
Fig. 3.14 and 3.15 are similar in reversed order and are suggested to reflect the combined 
effect of DMP and carbazole. The effect of APs on EROD activity appear to be dependent on 
several factors as the specific compound studied, whether the study is in vitro or in vivo, sex, 
reproductive stage, route of exposure and if exposure is mixed or not.  
 
Squared terms for all three compounds showed significant equal reduction of EROD activity, 
indicating that higher concentrations of DMP will interfere with EROD activity. Based on 
equal size of the square terms it is suggested that the general high contaminant load in the 
ternary mixtures interfere with EROD activity.  
 
4.4.2 Combined action measured as genotoxicity 
Exposure to produced water relevant compounds has effect on oxidative status in biological 
systems (Sturve et al., 2006; Bohne-Kjersem et al., 2009; Lie et al., 2009) and the GSH 
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dependent defence system (Hasselberg et al., 2004a). Produced water relevant compounds 
modulate CYP 1A activity (Goksoyr and Forlin, 1992; Aas et al., 2000; Hasselberg et al., 
2004b; Hylland et al., 2009). Catalytic activity of CYP 1A enhance ROS (Halliwell and 
Gutteridge, 1989; Bondy and Naderi, 1994; Zangar et al., 2004) and form reactive metabolites 
(Baird et al., 2005). Increased use of GSH in conjugation reactions is suggested to interfere 
with the GSH dependent defence against oxidative stress. Enzymes catalysing conjugation 
reactions are regulated via nuclear receptors (Bock and Kohle, 2004). Increased EROD 
activity was found after exposure of PLHC-1 to ternary mixtures (Fig. 3.9) and it was 
considered relevant to assess DNA damage.  
 
Clear modulation of DNA DSB was not seen in PLHC-1 exposed to three of the ternary 
mixtures, Fig. 3.17. These mixtures induced highest EROD activity and all have medium and 
high concentration of BaP. Based on this they were assumed to have high potency of inducing 
DNA damage. When these mixtures did not produce consistent trend in DNA DSB it was 
decided not to test the remaining mixtures. The method for determining DNA damage was not 
attempted improved due to time limitations.  
 
Separation of DNA from PLHC-1 on agarose gel has previously been successfully used to 
determine DNA damage potential of ternary mixtures with cadmium, copper, nickel and zink 
using the same protocol as used in this project. Direct and indirect processes can result in 
DNA DSB and several DNA repair systems are involved in repairing DNA strand breaks. 
Genotoxic effect of metals can be due to inhibition of DNA repair (Dally and Hartwig, 1997). 
Higher proportion of CA and SCE were seen in cells with non-functioning NRE and HR 
(Meschini et al., 2008).  
 
After exposure of PLHC-1 to 2.5×10
-5 
mg/mL BaP DNA adduct formation were found to be 
bell shaped with maximum amount of adducts detected after 12 hours exposure. Reduced 
amount of DNA DSB at longer exposure time was assumed to be due to enhanced activity of 
DNA repair mechanisms. Oxidative status was not affected and intrinsic GST activity 
suggested sufficient to detoxify activated BaP. Increasing RNA adducts concomitant with 
BaP concentration and concurrent with EROD activity were seen, and was proposed to be a 
better marker for DNA damage induced by reactive compounds (Smeets et al., 1999).  
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5 SUMMARY AND CONCLUSION  
The aims of this master project were to determine carbazoles potential for modifying CYP 1A 
activity measured as EROD activity, to evaluate interaction in ternary mixtures with carbazole 
and two compounds representing fractions contributing to toxicity of produced water, and also 
to study correlation between biotransformation activity and genotoxicity by measuring DNA 
DSB.  
 
It was hypothesized that compounds will modify EROD activity in PLHC-1 differently when 
present in ternary mixtures compared to single exposure. It was suggested that ternary 
mixtures inducing high EROD activity also will enhance formation of DNA DSB in PLHC-1 
cells. Carbazole was suggested to modify EROD activity induced by the other compounds.   
 
Exposure to carbazole modified EROD activity in PLHC-1 differently when exposed singly 
compared to exposure in ternary mixtures. Exposure in ternary mixtures resulted in significant 
induced EROD activity, while single exposure was significant only for one replicate at 
highest concentration. The difference can be suggested to be caused by an active metabolite of 
carbazole formed in oxidation catalyzed by CYPs. The significant, large, negative PLS 
regression coefficient for squared carbazole suggested interplay between carbazole and CYPs. 
Furthermore, BaP and carbazole can be suggested to induce EROD activity through different 
paths. Induction of CYPs by BaP is previously suggested to be via GNMT.  
 
One interaction term was significant in the PLS regression model, DMP×Carbazole, which 
reduced EROD activity. The interaction between these compounds was suggested to be 
caused by toxicokinetic interaction affecting biotransformation enzymes or chemical 
interaction. How EROD activity is modified after exposure to DMP is suggested to be 
dependent on exposure conditions. 
 
Carbazole was included in this project to study its potential for modifying CYP 1A activity 
singly and in mixtures. The results obtained suggest that carbazole contributes to EROD 
inducing potency in the ternary mixtures. Effect of carbazole on EROD activity is indicated to 
be dependent on co-exposed compounds, and how additional compounds present in produced 
water may affect the effect of carbazole are so far not known. Literature on concentration of 
carbazole in produced water and marine environment is not found. Environmental 
concentrations are likely to be lower than the highest concentration included and the results 
presented here are suggested to be relevant for effect of carbazole singly in the marine 
environment.  
 
Further studies on carbazoles potential of interacting with CYP 1A is needed. Non-
competitive ELISA or rt-qPCR are suggested as supplementary methods for obtaining 
information on protein or mRNA levels of CYP 1A in PLHC-1. Catalytic EROD activity after 
exposure to carbazole should also be evaluated as a function of time.  
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Catalytic EROD activity is presumed to be a good indication interplay between a compound 
and a biological systems. Determining extent of DNA damage by separating DNA 
electrophoretically did not give consistent result and the method is suggested to be more 
pertinent for determining genotoxicity of certain metals in PLHC-1. Statistical design and 
projection techniques are considered valuable tools when assessing toxicity of mixtures.   
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APPENDIX 1. SOLUTIONS 
 
1. Cultivating cells 
PBS, 1L, pH 7.4, autoclaved 
8 g NaCl 
0.2 g KCl 
1.44 g Na2HPO4 
0.24 g KH2PO4 
 
2.5% Trypsin with 1% EDTA 
1.07 g EDTA  
20 mL 2.5% Trypsin.  
 
Growth medium, 500 mL 
500 mL Mimimal Essential Medium, Eagle’s 
25 mL FBS 
5 mL Pencilin-streptomyocin  
 
70 % Ethanol, 1L 
730 mL 96% ethanol 
270 mL distilled water 
 
EDTA 0.5 M, 0.5 L, pH 8.0 
 93.5 g EDTA   
 
 
 
 
2. MTT-assay 
MTT-solution 
0.005 g MTT salt 
1 mL PBS 
 
MTT/Medium-solution, adjusted for number of wells 
20 µL MTT-solution 
180 µL growth medium 
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3. EROD-assay 
TRIS, 50 mM, 0.2 L, pH 7.8  
1.2114 g  
Distilled water 
 
BSA 5.32 mg/mL, pH 7.8 
106.4 mg BSA  
20 mL 50 mM Tris 
 
ER, 1000 µM,   
1 mg ER  
4.14 mL DMSO.  
 
NADPH, pH 7.8 
25 mg NADPH  
1 mL 50 mM TRIS  
 
 
 
 
4. Bradford-assay 
BSA 1mg/mL 
1 mg BSA  
Autoclaved milli-Q-water 
 
 
 
 
5. Gel Electrophoresis 
10% SDS, 100 mL 
 10 g SDS  
Distilled water 
 
Digestion buffer, 200 mL, pH 8 
 1.1688 g NaCl 
 0.2423 g TRIS  
 10 mL 0.5 M EDTA  
 10 mL 10% SDS 
 
Lambda-marker solution, 200 µL 
 100 µL λ/HIND III (50 µg)  
 37 µL λ-DNA (11 µg) 
 63 µL TE-buffer 
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5×TBE-buffer, 1 L, pH 8 
 54 g Trisbase 
 27.5 g H3BO3 
 20 mL 0.5 M EDTA 
 
TE- buffer, 500 mL, pH 8 
 0.6057 g Tris  
 1 mL 0.5 M EDTA 
 
EDTA 0.5 M, 0.5 L, pH 8 
 93.5 g EDTA  
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APPENDIX 2. MTT CYTOTOXICITY ASSAY 
 
Raw data and calculated average absorbance values for linear area for formazan formation for 
MTT assay in PLHC-1 are presented in Table 1. Raw data and calculated average percent cell 
survival in PLHC-1 are presented after exposure to concentration range of DMP, carbazole, 
BaP and mixtures in Table 2, 3, 4 and 5. Absorbance was measured at 550 nm with a plate 
reader. Values greater, smaller or equal to average values ± 2 standard deviations were 
considered outliers and disregarded. Individual experiments are marked with date. 
 
Average percent cell survival was calculated using equation 1: 
 
 
                
 
 
∑
  
  
                                                                                 (1) 
 
xi = values of absorbance of parallels 
n = number of parallels 
Av. = average absorbance of DMSO control treated cells 
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Table 1.  
Friday 17.09.10  
Conc. 
(cells/mL) 
500000 400000 250000 150000 100000 75000 50000 25000 15000 0 
P
a
ra
lle
lls
 
B 2.253 1.937 1.348 1.216 1.114 0.741 0.592 0.229 0.120 0.053 
C 1.855 1.922 1.411 1.538 0.959 0.837 0.559 0.205 0.128 0.051 
D 1.968 1.859 1.305 1.481 1.123 0.884 0.608 0.236 0.133 0.050 
E 1.911 1.843 1.366 1.577 1.239 0.797 0.587 0.253 0.147 0.048 
F 2.059 1.919 1.361 1.373 1.044 0.915 0.553 0.253 0.157 0.053 
G 1.861 1.628 1.117 1.566 0.981 0.656 0.488 0.184 0.191 0.060 
Av. 
absorbance 
1.985 1.851 1.318 1.459 1.077 0.805 0.565 0.227 0.146 0.053 
Std. dev. 0.15 0.12 0.10 0.14 0.10 0.10 0.04 0.03 0.03 0.00 
Thursday 23.09.10 
Conc. 
(cells/mL) 
200000 150000 125000 90000 75000 60000 50000 40000 25000 15000 
P
a
ra
lle
lls
 
B 1.698 1.279 0.966 0.723 0.764 0.553 0.398 0.306 0.257 0.106 
C 1.565 1.171 0.863 0.727 0.673 0.586 0.417 0.326 0.221 0.124 
D 1.762 1.302 1.011 0.804 0.749 0.552 0.400 0.327 0.197 0.114 
E 1.440 1.209 1.045 0.828 0.773 0.581 0.448 0.338 0.205 0.142 
F 1.629 1.264 1.064 0.752 0.798 0.555 0.434 0.295 0.163 0.127 
G 1.470 1.366 0.913 0,183* 0.698 0.545 0.437 0.307 0.206 0.133 
Av. 
absorbance 
1.594 1.265 0.977 0.767 0.743 0.562 0.422 0.317 0.208 0.124 
Std. dev. 0.13 0.07 0.08 0.05 0.05 0.02 0.02 0.02 0.03 0.01 
Friday 24.09.10  
Conc. 
(cells/mL) 
750000 500000 400000 250000 150000 100000 75000 50000 25000 15000 
P
a
ra
lle
lls
 
B 3.053 2.290 2.124 1.597 1.155 0.819 0.708 0.522 0.229 0.136 
C 3.162 2.385 2.130 1.646 1.215 1.042 0.662 0.471 0.209 0.129 
D 3.044 2.681 2.253 1.850 1.376 1.092 0.838 0.503 0.246 0.139 
E 3.406 2.622 2.140 1.857 1.259 1.145 0.773 0.524 0.238 0.165 
F 3.129 2.732 2.329 1.818 1.415 1.192 0.781 0.530 0.275 0.167 
G 3.521 2.422 2.062 1.732 1.180 1.055 0.869 0.500 0.264 0.168 
Av. 
absorbance 
3.219 2.522 2.173 1.754 1.267 1.058 0.772 0.508 0.244 0.151 
Std. dev. 0.20 0.18 0.10 0.12 0.11 0.13 0.08 0.02 0.02 0.02 
Saturday 25.09.10  
Conc. 
(cells/mL) 
500000 400000 250000 150000 125000 100000 75000 60000 50000 25000 
P
a
ra
lle
lls
 
B 2.447 2.253 1.741 1.290 1,549* 0.940 0.727 0.560 0.457 0.218 
C 3.493 2.653 1.819 1.353 1.142 0.912 0.724 0.610 0.441 0.194 
D 2.414 2.145 1.713 1.249 1.051 0.870 0.737 0.633 0.462 0.224 
E 2.454 2.177 1.916 1.398 0.974 0.892 0.753 0.579 0.422 0.200 
F 2.358 1.995 1.856 1.179 1.013 0.722 0.826 0.597 0,698* 0.195 
G 2.461 2.117 1.830 1.098 1.087 0.865 0.645 0.568 0.473 0.189 
Av. 
absorbance 
2.605 2.223 1.813 1.261 1.053 0.867 0.735 0.591 0.451 0.203 
Std. dev. 0.44 0.23 0.07 0.11 0.07 0.08 0.06 0.03 0.02 0.01 
* = values greater, smaller or equal to average absorbance ±2 std.dev. 
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Table 2.  
Tuesday 26.10.10 
2,5-
dimethyl 
phenol  
µM 1000 800 500 300 100 50 10 1 0.1 0 
mg/mL 1.2E-01 9.8E-02 6.1E-02 3.7E-02 1.2E-02 6.1E-03 1.2E-03 1.2E-04 1.2E-05 0.0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.409 0.422 0.500 0.576 0.752 0.688 0.704 0.610 0.589 0.647 
C 0.428 0.445 0.453 0.556 0.681 0.718 0.594 0.413 0.560 0.641 
D 0.430 0.393 0.460 0.523 0.692 0.701 0.670 0.679 0.647 0.808 
E 0.416 0.376 0.533 0.589 0.643 0.682 0.691 0.591 0.583 0.675 
F 0.353 0.381 0.466 0.633 0.570 0.674 0.475 0.596 0,279* 0.718 
G 0.344 0.408 0.524 0.612 0.758 0.687 0.699 0.592 0.569 0.695 
Av. % Cell survival 57 58 70 83 98 99 92 83 85 100 
% Std. dev. 5 4 5 6 10 2 13 13 5 9 
Thursday 4.11.10  
2,5-
dimethyl 
phenol  
µM 1000 800 500 300 100 50 10 1 0.1 0 
mg/mL 1.2E-01 9.8E-02 6.1E-02 3.7E-02 1.2E-02 6.1E-03 1.2E-03 1.2E-04 1.2E-05 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.430 0.413 0.380 0.660 0.655 0.713 0.614 0.695 0.703 0.566 
C 0.359 0.364 0.358 0.587 0.639 0.711 0.765 0.737 0.677 0.706 
D 0.326 0.327 0.335 0.600 0.668 0.719 0.754 0.596 0.681 0.695 
E 0.359 0.320 0.348 0.620 0,604* 0.676 0.761 0.774 0.733 0.721 
F 0.307 0.333 0.292 0.618 0.647 0.559 0.682 0.722 0.770 0.721 
G 0.398 0.342 0.335 0.565 0.642 0.660 0.626 0.676 0.738 0.753 
Av. % Cell survival 52 50 49 88 94 97 101 101 103 100 
% Std. dev. 7 5 4 5 2 9 10 9 5 9 
Thursday 02.12.10 A 
2,5-
dimethyl 
phenol  
µM 450 400 350 300 250 200 150 100 50 0 
mg/mL 5.5E-02 4.9E-02 4.3E-02 3.7E-02 3.1E-02 2.4E-02 1.8E-02 1.2E-02 6.1E-03 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
(5
5
0
 
n
m
) 
B 0.560 0.550 0.599 0.710 0.709 0.754 0.717 0.738 0.711 0.797 
C 0.615 0.568 0.554 0.697 0.727 0.800 0.719 0.704 0.714 0.624 
D 0.612 0.574 0.562 0.693 0.725 0.691 0.745 0.800 0.775 0.812 
E 0.648 0.559 0.618 0.695 0,802* 0.728 0.800 0.746 0.778 0.842 
F 0.574 0.619 0.660 0.740 0.734 0.501 0.761 0.818 0.751 0.948 
G 0.650 0.722 0.872 0.774 0.748 0.829 0.939 0.853 0.853 0.939 
Av. % Cell survival 74 72 78 87 88 87 94 94 92 100 
% Std. dev. 4 8 14 4 2 14 10 7 6 14 
Thursday 02.12.10 B 
2,5-
dimethyl 
phenol  
µM 450 400 350 300 250 200 150 100 50 0 
mg/mL 5.5E-02 4.9E-02 4.3E-02 3.7E-02 3.1E-02 2.4E-02 1.8E-02 1.2E-02 6.1E-03 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.717 0.595 0.651 0.759 0.777 0.798 0.745 0.821 0.760 0.779 
C 0.604 0.528 0.648 0.755 0.728 0.705 0.775 0.747 0.754 0.867 
D 0.642 0.525 0.617 0.692 0.771 0.709 0.823 0.721 0.759 0.826 
E 0.694 0.566 0.592 0.592 0.710 0.743 0.768 0.692 0.805 0.875 
F 0.573 0.569 0.626 0.707 0.706 0.700 0.704 0.743 0.791 0.753 
G 0.680 0.628 0.717 0.673 0.776 0.797 1,155* 0.721 0.852 0.914 
Av. % Cell survival 78 68 77 83 89 89 91 89 94 100 
% Std. dev. 7 5 5 7 4 5 5 5 5 7 
* = values greater, smaller or equal to average absorbance ±2 std.dev.  
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Table 3. 
Thursday 28.10.10 
Carbazole  
(µM) 1000 800 500 300 100 50 10 1 0.1 0 
(mg/mL) 1.7E-01 1.3E-01 8.4E-02 5.0E-02 1.7E-02 8.4E-03 1.7E-03 1.7E-04 1.7E-05 0.0E+00 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.343 0.318 0.318 0.320 0.561 0.350 0.680 0.604 0.592 0.521 
C 0.347 0.292 0.299 0.352 0.628 0.364 0.626 0.516 0.653 0.545 
D 0.366 0.343 0.310 0.364 0.579 0.607 0.574 0.593 0.540 0.466 
E 0.368 0.297 0.306 0.380 0.589 0.699 0.610 0.623 0.552 0.453 
F 0.339 0.319 0.328 0.391 0.650 0.411 0.582 0.632 0.708 0.570 
G 0.365 0.307 0.349 0.387 0.607 0.346 0.681 0.669 0.573 0.666 
Av. % Cell survival 66 58 59 68 112 86 117 113 112 100 
% Std. dev. 2 3 3 5 6 28 9 10 12 14 
Thursday 11.11.10 
Carbazole  
(µM) 10 7 5 3 2 1 0.1 0.01 0.001 0 
(mg/mL) 1.7E-03 1.2E-03 8.4E-04 5.0E-04 3.3E-04 1.7E-04 1.7E-05 1.7E-06 1.7E-07 0.0E+00 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.102 0.485 0.488 0.407 0.327 0.332 0.413 0.405 0.416 0.585 
C 0.544 0.462 0,403* 0.444 0.278 0.318 0.369 0.400 0.381 0.567 
D 0.499 0.503 0.494 0.403 0.346 0.361 0.386 0,353* 0.399 0.522 
E 0.596 0.403 0.529 0.388 0.383 0.233 0.373 0.397 0.422 0.551 
F 0.595 0.399 0.501 0.448 0.386 0.381 0.391 0.400 0.431 0.501 
G 0.439 0.498 0.508 0.424 0.381 0.417 0.410 0.402 0.424 0.520 
Av. % Cell survival 85 85 93 77 65 63 72 74 76 100 
% Std. dev. 34 9 3 4 8 12 3 1 3 6 
Thursday 02.12.10 A 
Carbazole  
(µM) 10 7 5 3 2 1 0.1 0.01 0.001 0 
(mg/mL) 1.7E-03 1.2E-03 8.4E-04 5.0E-04 3.3E-04 1.7E-04 1.7E-05 1.7E-06 1.7E-07 0.0E+00 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.748 0.696 0.646 0.593 0.708 0.757 0.755 0.743 0.627 0.606 
C 0.780 0.685 0.692 0.757 0.679 0.793 0.773 0.707 0.714 0.706 
D 0.657 0.531 0.803 0.742 0.718 0.766 0.786 0.708 0.716 0.441 
E 0.733 0.718 0.772 0.749 0.552 0.780 0.785 0.751 0.692 0.691 
F 0.726 0.753 0.546 0.819 0.676 0.780 0.862 0.851 0.769 0.362 
G 0.455 0.717 0.796 0.836 0.779 0.830 0.810 0.861 0.830 0.770 
Av. % Cell survival 115 115 119 126 115 132 133 129 122 100 
% Std. dev. 20 13 17 14 13 4 6 12 12 27 
Thursday 02.12.10 B 
Carbazole  
(µM) 10 7 5 3 2 1 0.1 0.01 0.001 0 
(mg/mL) 1.7E-03 1.2E-03 8.4E-04 5.0E-04 3.3E-04 1.7E-04 1.7E-05 1.7E-06 1.7E-07 0.0E+00 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.694 0.671 0.653 0.737 0.674 0.774 0.660 0.782 0.751 0.627 
C 0.785 0.682 0.670 0.773 0.676 0.676 0.658 0.717 0.709 0.627 
D 0.679 0.655 0.639 0.723 0.694 0.729 0.757 0.723 0.685 0.681 
E 0.403 0.703 0.728 0.728 0.713 0.769 0.715 0.759 0.534 0.723 
F 0.741 0,555* 0.711 0.699 0.606 0.651 0.697 0.748 0.733 0.657 
G 0.743 0.649 0.690 0.782 0.694 0.732 0.738 0.751 0.771 0.724 
Av. % Cell survival 100 100 101 110 100 107 105 111 104 100 
% Std. dev. 21 3 5 5 6 7 6 4 13 7 
* = values greater, smaller or equal to average absorbance ±2 std.dev.  
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Table 4.  
Thursday 02.12.10 A 
Benzo(a) 
pyrene  
(µM) 10 7 5 2 1 0.5 0.1 0.01 0.001 0 
(mg/mL) 2.5E-03 1.8E-03 1.3E-03 5.0E-04 2.5E-04 1.3E-04 2.5E-05 2.5E-06 2.5E-07 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.306 0.319 0.273 0.298 0.328 0.341 0.341 0.315 0.298 0.338 
C 0.303 0.280 0.298 0.288 0.318 0.314 0.350 0.327 0.280 0.334 
D 0.329 0.286 0.274 0.160 0.294 0.292 0.356 0.279 0.209 0.337 
E 0.328 0.300 0.301 0.268 0.310 0.328 0.380 0.311 0.306 0.368 
F 0.332 0.289 0.285 0.260 0.280 0.309 0.288 0.308 0.246 0.288 
G 0.363 0.292 0.255 0.262 0.310 0.315 0.365 0.365 0.282 0.310 
Av. % Cell survival 99 89 85 78 93 96 105 96 82 100 
% Std. dev. 7 4 5 15 5 5 10 9 11 8 
Thursday 02.12.10 B 
Benzo(a) 
pyrene  
(µM) 10 7 5 2 1 0.5 0.1 0.01 0.001 0 
(mg/mL) 2.5E-03 1.8E-03 1.3E-03 5.0E-04 2.5E-04 1.3E-04 2.5E-05 2.5E-06 2.5E-07 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.364 0.278 0.285 0.291 0.323 0.296 0.342 0.344 0.349 0.303 
C 0.288 0,287* 0.295 0.303 0.305 0.310 0.318 0.319 0.324 0.402 
D 0.328 0.280 0.297 0.296 0.312 0.331 0.325 0.314 0.338 0.289 
E 0.319 0.286 0.298 0.319 0.307 0.313 0.345 0.320 0.360 0.333 
F 0.325 0.276 0.313 0.285 0.331 0.338 0.350 0.335 0.364 0.340 
G 0.322 0.279 0.313 0.295 0.344 0.336 0.340 0.355 0.341 0.368 
Av. % Cell survival 96 82 89 88 94 95 99 98 102 100 
% Std. dev. 7 1 3 3 4 5 4 5 4 12 
Thursday 09.12.10 B 
Benzo(a) 
pyrene  
(µM) 10 7 5 2 1 0.5 0.1 0.01 0.001 0 
(mg/mL) 2.5E-03 1.8E-03 1.3E-03 5.0E-04 2.5E-04 1.3E-04 2.5E-05 2.5E-06 2.5E-07 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.324 0.305 0.299 0.309 0.322 0.348 0.347 0.368 0.349 0.340 
C 0.330 0.302 0.294 0.281 0.276 0.311 0.355 0.364 0.354 0.357 
D 0.327 0.316 0.316 0.272 0.273 0.313 0.364 0.339 0.370 0.336 
E 0.327 0.288 0.291 0.324 0.326 0.301 0.367 0.353 0.372 0.360 
F 0.287 0.282 0.308 0.293 0.320 0.332 0.371 0.332 0.380 0.347 
G 0.283 0.320 0.320 0.306 0.316 0.351 0.399 0.360 0.365 0.356 
Av. % Cell survival 90 86 87 85 87 93 105 101 104 100 
% Std. dev. 6 4 3 6 7 6 5 4 3 3 
* = values greater, smaller or equal to average absorbance ±2 std.dev. 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2 
X 
 
Table 5.  
Sunday 06.03.10 Mix. 1-9 (1)  
Mixture 1 2 3 4 5 6 7 8 9 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.606 0.637 0.580 0.615 0.632 0.655 0.687 0.705 0.600 0.680 
C 0.585 0.697 0.625 0.633 0.663 0.602 0.656 0.676 0.645 0.543 
D 0.579 0.687 0.665 0.550 0.787 0.667 0.734 0.627 0.625 0.572 
E 0.605 0.672 0.689 0.594 0.782 0.658 0.675 0.678 0.549 0.528 
F 0.670 0.725 0.660 0.634 0.765 0.683 0.750 0.706 0.694 0.595 
G 0.618 0.685 0.684 0.661 0.786 0.740 0.779 0.708 0.786 0.593 
Av. % Cell 
survival 104 117 111 105 126 114 122 117 111 100 
% Std. dev. 6 5 7 7 12 8 8 5 14 9 
Sunday 06.03.10 Mix. 1-9 (2)  
Mixture 1 2 3 4 5 6 7 8 9 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.546 0.575 0.548 0.540 0.690 0.594 0.540 0.505 0.590 0.488 
C 0.552 0.613 0.561 0.534 0.649 0.629 3,747* 0.630 0.608 0.555 
D 0.599 0.635 0.597 0.607 0.688 0.689 0.669 0.673 0.592 0.564 
E 0.613 0.622 0.602 0.585 0.716 0.706 0.697 0.693 0.691 0.517 
F 0.622 0.632 0.615 0.593 0.735 0.693 0.628 0.659 0.692 0.610 
G 0.607 0.448 0.573 0.618 0.721 0.649 0.612 0.755 0.720 0.598 
Av. % Cell 
survival 106 106 105 104 126 119 113 117 117 100 
% Std. dev. 6 13 5 6 6 8 11 15 11 8 
Sunday 06.03.10 Mix. 10-17 (1)  
Mixture 10 11 12 13 14 15 16 17 0 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.633 0.640 0.573 0.648 0.645 0.595 0.669 0.686 0.632 0.598 
C 0.698 0.695 0.580 0.655 0.686 0.595 0.613 0.557 0.644 0.553 
D 0.690 0.677 0.609 0.623 0.631 0.585 0.629 0.650 0.615 0.512 
E 0.702 0.726 0.615 0.650 0.648 0.592 0.682 0.664 0.625 0.538 
F 0.695 0.699 0.598 0.638 0.627 0.584 0.674 0.639 0.677 0.635 
G 0.679 0.688 0.598 0.695 0.699 0.611 0.686 0.666 0.713 0.519 
Av. % Cell 
survival 122 123 106 117 117 106 118 115 116 100 
% Std. dev. 5 5 3 4 5 2 5 8 7 9 
Sunday 06.03.10 Mix. 10-17 (2)  
Mixture 10 11 12 13 14 15 16 17 0 0 
A
b
s
o
rb
a
n
c
e
  
  
  
  
  
  
  
  
(5
5
0
 n
m
) 
B 0.608 0.645 0.549 0.648 0.646 0.573 0.602 0.585 0.601 0.529 
C 0.657 0.700 0.549 0.658 0.631 0.588 0.610 0.640 0.561 0.571 
D 0.707 0.712 0.580 0.655 0.639 0.619 0.650 0.644 0.527 0.506 
E 0.695 0.736 0.596 0.677 0.665 0.566 0.642 0.697 0.610 0.581 
F 0.662 0.641 0.570 0.636 0.635 0.579 0.661 0.670 0.606 0.544 
G 0.691 0.726 0.559 0.612 0.616 0.551 0.639 0.724 0.645 0.601 
Av. % Cell 
survival 121 125 102 117 115 104 114 119 107 100 
% Std. dev. 6 7 3 4 3 4 4 9 7 6 
* = values greater, smaller or equal to average absorbance ±2 std.dev 
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APPENDIX 3. EROD ASSAY 
 
 
 
 
 Standard curve  
 
 
 
Standard curve relating fluorescence (mFU, y-axis) to amount of resorufin (µM, x-axis). The 
equation presented in the figure was used when calculating amount of resorufin (Anne 
Mortensen and Martine Horn Gjernes). 
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 Calculated EROD activity single compounds 
Calculated average EROD activities are presented in Table 1, 2 and 3 for 2,5-diemthylphenol 
(DMP), carbazole and benzo(a)pyrene (BaP), respectively. Fluorescence (mFU) and total 
protein (µg/mL) measured in PLHC-1 exposed are presented in Table 4, 5 and 6, for DMP, 
carbazole and BaP, respectively. Calculation of resorufin was performed according to the 
equation given in the standard curve:  
 
 
               
                         
      
                                         (1) 
 
 
Table 1.   
DMP 
(µM) 
DMP 
(mg/mL) 
F 28.01 (1) F 28.01 (2) Tu 01.02  W 09.02  AVERAGE 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
150 1.8E-02 -6482 2064 -3991 1053 -2456 698 -5536 3351 -4616 1769 
100 1.2E-02 -5644 578 -3959 560 -1951 406 -3376 1618 -3732 1528 
50 6.1E-03 -5503 955 -4999 1215 -2472 267 -5637 1517 -4653 1479 
25 3.1E-03 -9502*   -3477 1847 -2983 1027 -4303 1174 -3587 667 
5 6.1E-04 -7508 2731 -3934 1745 -2853 1103 -5658 965 -4988 2038 
0.1 1.2E-05 -9727 5352 -5176 1696 -3733 826 -5155 527 -4688 2609 
DMSO 0 -6876* 223 -2993 1920 -1889 35 -2143 36 -2342 578 
Medium 0 -6608 2215 -4215 1044 -1621 497 -2235 796 -3670 2250 
*Values not presented/included 
 
 
Table 2. 
Carbazole 
(µM) 
Carbazole 
(mg/mL) 
Thursday 20.01 
Thursday 
27.01 
Monday 31.01  Monday 7.02  AVERAGE 
EROD 
activity  
Std 
dev 
EROD 
activity  
Std 
dev 
EROD 
activity  
Std 
dev 
EROD 
activity  
Std 
dev 
EROD 
activity 
Std 
dev 
7 1.2E-03 -1510 620 -684 180 133 258 -875 374 -734 677 
5 8.4E-04 -700 310 -540 431 -892 655 -1386 712 -879 367 
3 5.0E-04 -1376 339 -661 406 -558 223 -1494 336 -1022 481 
1 1.7E-04 -756 109 -658 329 -830 258 -871 540 -779 94 
0.5 8.4E-05 -1261 297 -728 580 -928 239 -1354 460 -1068 291 
0.01 1.7E-06 -638 488 -773 314 -983 272 -1692 291 -1022 469 
DMSO 0 -923 533 -970 266 -1260 313 -1929 267 -1271 463 
Medium 0 -405 278 -899 468 -1049 307 -1770 526 -1031 564 
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Table 3. 
BaP 
(µM) 
BaP 
(mg/mL) 
M 17.01 Th 20.01 Th 27.01  W 02.02  AVERAGE 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
EROD 
activity 
Std 
dev 
10 2.5E-03 -2074 470 -2294 317 447 234 -672 446 -1149 1283 
1 2.5E-04 2893 1020 2917 663 6457 1818 4594 886 4215 1694 
0.5 1.3E-04 4330 375 4154 1882 6003 296 4546 611 4758 845 
0.1 2.5E-05 1837 1069 1523 240 2770 403 2333 754 2116 549 
0.01 2.5E-06 -88 197 -1039 831 203 332 -1319 216 -561 733 
DMSO 0 -1076 831 -2334 809 -905 345 -976 251 -1323 678 
Medium 0 -1208 545 -2125 628 -942 429 -1327 155 -1401 509 
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 Raw data single compounds 
 
Table 3.  
    F 28.01 (1) F 28.01 (2) Ti 01.02 O 09.02  
D
M
P
 
ID mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
M
e
d
iu
m
 
1 44 47 91 104 58 51 47 202 246 148 45 51 431 459 384 52 51 403 414 435 
2 45 46 87 108 98 45 47 145 209 118 52 50 386 417 344 48 50 267 320 311 
3 48 49 53* 143 110 47 47 197 221 178 52 57 474 500 325 55 43 242 268 231 
D
M
S
O
 4 45 50 86 55 108 43 46 192 175 191 50 46 454 479 435 54 48 242 315 273 
5 42 47 113 109 122 49 51 211 231 159 49 50 443 434 365 50 52 260 311 279 
6 46 44 0 0 0 44 32 169 227 191 49 50 391 414 392 41 44 0 0 0 
1
5
0
 µ
M
 
7 41 46 48* 92 117 44 50 188 253 174 46 44 378 366 350 43 45 36* 152 104 
8 45 51 10 41 0 44 45 191 231 127 45 46 304 382 380 45 43 169 107 174 
9 47 50 70* 104 7* 44 52 275 75* 202 51 53 366 398 356 53 54 274 244 0* 
1
0
0
 µ
M
 
10 46 47 79 126 0* 46 48 228 199 201 49 47 389 434 399 48 53 348 483 317 
11 46 49 74 144 52* 43 49 201 196 155 48 48 380 412 354 46 54 172 206 170 
12 45 45 97 183 50* 46 49 228 233 177 51 52 416 458 427 49 39 250 254 132 
5
0
 µ
M
 13 47 47 54* 145 80 45 47 223 231 192 47 46 330 420 325 38 44 206 188 148 
14 45 47 0* 105 0* 47 46 143 114 0* 46 49 334 381 315 44 40 41 0 0 
15 49 50 92 124 89 45 47 218 170 145 47 52 401 335 329 106* 41 261 306 230 
2
5
µ
M
 16 44 43 34 0 45 47 51 154 128 111 43 47 197 299 269 46 44 317 325 232 
17 117 26 112 100 11 51 56 252 266 284 60* 46 377 367 311 50 44 247 205 184 
18 48 36 109 85 36 49 47 183 211 155 50 51 374 327 328 50 49 64* 31* 123 
5
 µ
M
 19 49 45 0* 72 0* 44 49 54* 186 109 47 53 334 372 297 47 42 10 0 94 
20 46 42 0* 84 0* 48 49 311 373 321 45 43 263 312 228 45 47 237 175 134 
21 47 49 115 137 60* 46 46 211 220 170 50 48 356 342 379 46 44 199 109 150 
0
,1
 µ
M
 22 45 43 64 41 0* 48 47 110 0 0 44 43 216 243 273 51 53 0 0 0 
23 50 49 0* 101 0* 48 45 161 171 131 44 48 356 326 283 50 48 173 0* 129 
24 44 49 0* 87 51 50 48 185 213 180 45 46 335 263 271 49 48 184 107 118 
B
la
n
k
 
B 49 51   
 
  52 52   
 
  65 50   
 
  51 60   
 
  
B 50 52       52 57       49 58       54 52       
*Values not included in calculations 
123 Parallels not included in average 
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Table 4. 
C
a
rb
a
z
o
le
 
  Thursday 20.01 Thursday 27.01 (1) Monday 31.01  Monday 7.02  
ID mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
M
e
d
iu
m
 
1 39 48 348 334 322 44 49 601 551 601 45 48 560 553 574 54 54 534 516 224 
2 43 50 366 322 303 52 52 590 587 577 48 47 538 523 532 48 53 540 483 510 
3 41 48 150* 335 0* 45 44 553 555 460 41 42 579 564 599 47 42 493 500 485 
D
M
S
O
 4 39 51 355 378 301 52 46 580 594 594 43 45 554 538 430 48 49 552 562 527 
5 41 43 311 329 307 48 46 531 590 553 41 43 549 501 468 46 46 520 460 475 
6 35 40 406 450 376 45 43 575 632 542 46 48 540 522 482 48 49 482 500 484 
1
0
 µ
M
 7 42 41 251 342 250 47 48 556 620 586 60 54 512 495 402 60 59 459 619 468 
8 44 38 285 387 340 47 49 645 809 648 59 55 478 493 486 55 53 481 438 512 
9 37 40 211 0* 260 52 52 530 496 355 56 51 461 532 455 48 63 528 557 527 
1
 µ
M
 10 37 48 234 279 339 58 52 704 616 530 50 46 393 470 425 58 59 531 577 539 
11 41 45 351 217 422 54 45 708 615 581 46 46 308 422 345 49 49 476 621 378 
12 49 42 234 156 386 49 43 719 622 589 49 57 550 603 491 51 46 513 529 509 
0
,5
 µ
M
 13 41 42 238 226 343 47 43 640 616 566 50 49 572 668 532 55 52 548 543 543 
14 38 42 249 184 304 49 50 701 583 608 44 46 776 785 734 47 53 457 498 433 
15 43 40 306 268 346 52 53 803 1078* 636 54 48 664 721 672 47 53 543 595 458 
0
,1
 µ
M
 16 41 47 270 228 338 47 47 640 503 522 45 56 460 481 401 53 49 543 562 437 
17 41 43 371 347 337 48 53 463 502 449 45 49 610 612 568 56 61 499 616 600 
18 45 40 406 380 373 55 51 538 540 554 47 43 548 574 512 62 53 622 626 676 
0
,0
1
 µ
M
 
19 39 39 316 334 308 45 42 516 564 538 48 46 570 581 551 56 55 496 420 518 
20 42 42 323 376 277 55 48 575 594 755 39 49 538 563 554 56 53 493 463 490 
21 41 39 327 368 308 55 49 618 584 652 51 43 653 639 631 47 48 503 501 564 
M
e
d
iu
m
 
22 45 36 368 294 338 48 44 506 579 509 47 47 423 437 367 48 52 536 500 521 
23 49 41 324 378 322 54 49 483 460 521 48 45 488 504 379 48 47 470 488 502 
24 42 48 380 356 357 49 50 584 527 668 47 53 450 493 372 53 51 460 446 548 
B
la
n
k
 
B 38 38   
 
  47 49   
 
  47 50   
 
  60 59   
 
  
B 45 41       48 53       51 45       52 57       
 *Values not included in calculations 
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Table 5. 
    M 17.01 To 20.01 To 27.01 (2) O 02.02  
B
a
P
 
ID mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
mFU 
Total prot. 
(µg/mL) 
M
e
d
iu
m
 
1 50 51 407 448 334 50 54 44 338 132 58 53 648 617 627 41 49 383 366 400 
2 58 54 506 545 416 57 52 159 328 207 59 62 660 624 606 46 47 440 386 377 
3 45 59 675 696 502 53 58 312 444 402 60 68 656 708 634 48 44 382 369 319 
D
M
S
O
 4 63 59 468 448 422 51 46 348 412 313 65 58 638 695 665 46 52 383 368 324 
5 52 56 380 545 312 53 60 320 378 357 65 61 654 640 614 44 47 423 411 409 
6 48 53 390 462 341 55 47 300 340 232 56 57 625 630 437* 48 50 383 403 372 
1
0
 µ
M
 7 50 53 447 469 380 55 53 246 273 209 72 75 613 593 564 45 49 357 389 357 
8 45 45 427 504 427 57 55 182 388 170 76 79 670 712 623 50 55 362 216 313 
9 44 46 17* 489 412 54 57 283 281 227 79 66 630 759 594 49 53 349 367 355 
1
 µ
M
 10 91 101* 437 462 216* 83 102* 299 292 354 174 168 712 786 679 89 89 410 413 406 
11 77 74 465 398 434 79 79 293 321 300 118 122 554 676 551 80 41 313 359 286 
12 83 79 399 443 344 80 73 326 332 313 125 141 673 716 664 83 73 390 450 390 
0
,5
 µ
M
 13 87 103* 383 373 310 87 89 311 302 262 103 87 603 647 614 87 83 380 408 339 
14 108* 85 405 333 306 90 94 319 268 324 127 133 616 679 614 81 72 358 373 337 
15 96 97 417 460 450 71 70 165 193 186 146 154 765 832 775 88 85 404 453 403 
0
,1
 µ
M
 16 67 64 265 371 405 72 68 289 222 277 103 93 571 638 536 65 61 319 328 266 
17 74 81 401 384 292 76 67 242 218 271 104 89 700 691 736 57 54 452 413 349 
18 68 73 521 455 418 76 71 317 411 333 120 97 824 759 759 69 68 266 346 314 
0
,0
1
 µ
M
 
19 64 61 355 468 411 68 59 262 332 302 78 67 655 640 665 46 48 303 312 234 
20 58 67 576 541 557 61 61 222 270 144 77 74 688 689 688 48 48 303 286 242 
21 64 56 447 467 429 60 54 236 303 200 68 68 729 781 683 50 46 343 353 319 
B
la
n
k
 
B 59 55 
  
  57 60 
   57 66   
  49 49 
  
  
B 55 54       56 59       68 62       45 47       
  *Values not included in calculations 
123 Parallels not included in average 
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Calculated EROD values mixtures 
Calculated average EROD activities are presented in Table 6 for all 17 mixtures, DMSO 
control and medium control. Fluorescence (mFU) and total protein (µg/mL) measured in 
PLHC-1 exposed to mixtures 1-6, mixtures 7-12 and mixtures 13-17 are presented in Table 7, 
9 and 10, respectively. Mixtures 6 were measure for two parallels separately and raw data 
from these are presented in Table 8. Fluorescence was measured as two parallels, total protein 
as three parallels and three parallel samples were run for each concentration tested. 
Calculation of resorufin was performed according to equation 1. 
 
 
Table 6. 
  1 2 3 
Mixture 
EROD 
activity 
Std dev 
EROD 
activity 
Std dev 
EROD 
activity 
Std dev 
1 -1278.0 279.9 -456.1 373.3 21.8 452.8 
2 -1287.7 475.0 -1337.2 223.2 -527.8 185.9 
3 63.8 218.5 998.2 464.5 1307.6 225.9 
4 -888.9 90.3 -130.5 334.5 418.0 354.7 
5 4939.7 370.5 4887.9 1014.9 4769.5 848.1 
6 7771.3 341.9 7136.6 593.1 6234.1 534.5 
7 6419.3 2370.6 7096.6 461.7 7013.8 671.7 
8 4709.7 2560.4 5044.3 468.1 5039.1 514.4 
9 5698.7 1280.3 5936.7 163.4 5095.5 324.0 
10 5008.4 281.4 4074.9   3938.7 423.0 
11 3750.4 2159.0 3480.0 250.5 3656.0 105.5 
12 6852.6 1355.1 6344.2 623.4 5865.8 1262.3 
13 1335.8 395.4 1353.8 32.3 1320.1 604.8 
14 9598.4 167.9 8967.3 433.8 7540.2 904.9 
15 10491.8 621.2 7927.0 487.5 9276 84.9 
16 7625.4 663.9 6955.4 864.4 8099.9 457.6 
17 7671.4 569.7 7062.2 453.9 7261.6 239.6 
DMSO 4.7 172.7 6.9 111.2 -879.4 262.3 
Medium -600.6 669.1 -221.1 453.6 -20.5 590.6 
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Table 7. 
Mix.     
1-6 
  1 2 3 
ID mFU 
Total protein 
(µg/mL) 
mFU 
Total protein 
(µg/mL) 
mFU 
Total protein 
(µg/mL) 
1 
1 42 44 271 347 295 43 42 265 352 332 44 44 381 428 423 
2 40 44 335 426 407 41 40 370 405 359 44 45 421 497 480 
3 45 45 305 402 343 39 36 423 363 414 40 37 439 440 484 
2 
4 43 45 442 505 474 37 36 508* 321 230 38 36 433 471 445 
5 41 45 345 405 381 37 37 313 409 307 40 39 497 502 475 
6 42 42 164* 292 174* 39 36 258 202 113* 38 38 460 498 491 
3 
7 52 47 238 321 303 46 44 0* 112 0* 56 50 525 572 594 
8 48 53 350 392 373 46 44 182 273 255 53 52 521 529 547 
9 49 51 232 350 340 48 49 206 297 198 56 55 510 520 526 
4 
10 47 43 83* 266 200 43 43 189 287 241 48 43 410 447 416 
11 46 47 263 396 288 43 39 194 326 221 44 41 446 445 452 
12 46 45 302 359 317 44 43 0* 213 0* 49 46 398 448 463 
5 
13 71 73 226 337 267 66 62 290 355 280 73 74 460 546 500 
14 70 68 0* 246 175 61 62 247 282 232 75 74 365 403 406 
15 77 75 341 347 306 70 69 298 309 196 83 76 373 455 432 
6 
16                     84 85 407 435 338 
17     
  
      
  
  82 84 419 368 366 
18                     80 47 428 381 425 
DMSO 
19 42 44 220 315 257 37 37 313 305 162* 38 37 386 315 0* 
20 38 37 318 377 353 38 37 272 242 200 41 41 436 440 437 
21 48 45 530 556 520 40 40 270 349 0* 41 39 427 430 417 
Blank 
22 41 41       33 32       37 32       
23 47 44 
  
  39 39 
  
  36 35 
  
  
24 46 45       38 38       37 37       
 *Values not included in calculations 
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Table 8. 
Mix. 6 mFU 
Total protein 
(µg/mL) 
6 
105 98 285 358 367 
88 86 247 250 328 
101 96 303 216* 392 
6 
92 93 315 387 356 
108* 97 400 316 335 
118 105 391 352 386 
DMSO 
62 55 312 287 330 
58 53 160 210 210 
55 52 298 400 306 
Blank 45 43 
  
  
  46 46 
  
  
  50 47 
  
  
  52 49       
   *Values not included in calculations 
   123 Parallels not included in average 
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Table 9. 
    1 2 3 
Mix.     
7-12 
ID mFU 
Total protein 
(µg/mL) 
mFU 
Total protein 
(µg/mL) 
mFU 
Total protein 
(µg/mL) 
7 
1 71 69 57* 227 193 110 109 414 455 446 93 95 394.7 424.1 385.8 
2 61 55 305 360 310 88 89 381 457 422 95 93 397.7 455.1 458.3 
3 56 52 64* 94* 152 94 80 333 392 388 86 84 388.3 448.6 361.9 
8 
4 55 54 253 313 274 73 74 367 395 377 61 61 276.4 327.8 286.7 
5 57 60 56* 332 185 72 76 406 439 441 78 72 342.5 453.7 433 
6 58 54 0* 111 0* 81 81 388 460 453 74 73 322.4 391.7 298.6 
9 
7 70* 60 162 168 76 78 74 419 422 418 75 69 283.2 367.4 422* 
8 69* 52 111 137 126 88 85 434 490 478 72 69 307.6 366.5 428* 
9 66 67 0* 134 0* 84 84 402 447 288* 73 71 469.7 473.4 387.6 
10 
10 58 63 266 264 184 54 57 290 401* 295 94 89 418.4 478.5 404.8 
11 60 57 73* 189 72* 74 69 463 491 374 72 64 363.3 453.9 243* 
12 60 59 208 241 181 58 57 347 470* 339 73 76 422 494.6 417.9 
11 
13 51 51 123 179 0* 64 57 303 403 347 68 64 378.4 440.8 323.8 
14 56 58 135 171 147 61 63 259 436 349 64 51 0 0 0 
15 46 48 116 244 161 68 64 351 439 235* 67 67 363.7 444.3 338.6 
12 
16 57 46 115 200 197 78 77 302 371 287 74 62 292 306 0* 
17 58 61 149 134 0* 75 79 377 330 380 82 81 359.6 345.1 322.4 
18 69 62 213 153 55* 98 87 401 406 454 70 30 348.5 397.9 291.8 
DMSO 
19 33 36 218 183 99* 35 38 307 389 262 41 38 356.6 406.7 300.4 
20 38 40 192 125 82* 37 42 375 414 389 41 42 387.6 360.3 116.3 
21 40 39 157 136 0* 35 35 365 455 499 41 41 494.8 491.8 366.2 
Blank 
22 40 38 
   
28 26 
   35 35 
      
23 36 34 
   
39 38 
   40 38   
  
24 32 34       41 41       40 35       
*Values not included in calculations 
123 Parallels not included in average 
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Table 10. 
    1 2 3 
Mix.     
13-17 
ID mFU 
Total protein 
(µg/mL) 
mFU 
Total protein 
(µg/mL) 
mFU 
Total protein 
(µg/mL) 
13 
1 53 51 347 405 380 63 61 561 588 601 56 58 330 344 320 
2 52 47 399 464 433 59 64 566 588 588 53 52 331 337 351 
3 44 41 197 0* 0* 52 48 499 508 554 50 48 470 492 436 
14 
4 117 100 427 466 395 131 141 554 665 661 87 80 295 311 320 
5 106 102 383 406 382 136 130 529 601 583 88 90 390 332 353 
6 111 103 306 358 0* 142 136 565 590 611 89 95 337 306 309 
15 
7 112 93* 400 455 423 120 124 598 594 715* 78 76 299 342 308 
8 113 108 362 419 369 130 127 559 622 694 73 70 253 318 305 
9 95 90 498 457 461 129 126 538 620 548 77 72 313 349 333 
16 
10 96 91 397 405 424 118 103 591 647 603 91 87 302 300 63 
11 92 79 327 339 302 160 148 835 908* 801 86 77 303 377 389 
12 84 79 305 392 0* 119 113 572 634 596 98 91 376 382 351 
17 
13 95 90 399 460 438 121 108 523 544 522 94 94 338 419 382 
14 95 88 416 391 390 121 108 567 588 621 87 85 306 364 301 
15 108 104 460 513 446 115 111 575 571 584 124 130 442 539 544 
DMSO 
16 40 45 389 433 405 48 48 491 544 467 43 40 328 329 324 
17 45 41 387 414 472 51 49 649 562 589 44 45 321 288 312 
18 41 41 332 343 0* 49 49 449 527 493 43 42 337 382 315 
Medium 
19 39 36 204 0* 0* 43 41 586 584 545 47 40 317 362 382 
20 41 39 403 378 370 50 50 618 549 632 48 50 226 275 253 
21 43 40 333 270 0* 50 47 530 639 580 51 47 324 318 288 
Blank 
22 33 32       46 41       44 43       
23 34 36   
 
  44 41   
 
  44 44   
 
  
24 37 41       42 40       35 36       
*Values not included in calculations 
123 Parallels not included in average 
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Replicates not included in the PLS model 
Mixtures
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
E
R
O
D
 a
c
ti
v
it
y
(p
m
o
l 
re
s
o
ru
fi
n
/m
in
/m
g
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ro
te
in
)
-6000
-4000
-2000
0
2000
4000
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8000
10000
12000
14000
 
Catalytic EROD activity was determine for five to six replicates for each mixture. Replicates 
not used in the PLS regression model are illustrated here. Raw data are not presented. 
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APPENDIX 4. CONCENTRATION OF PRODUCED WATER 
RELEVANT COMPOUNDS 
 
Table 1. 
Compound 
(group) 
Concentration 
(mg/mL) 
Locality Refrence 
C2-alkylphenols 0.51 Brage Utvik 1999 
" 0.75 Oseberg F " 
" 0.95 Oseberg C " 
" 0.41 Troll " 
2,5-DMP 0.11 Oseberg C Boitsov et al., 2004 
" 0.02 Troll B Boitsov et al., 2007 
" 0.10 Statfjord A " 
" 0.07 Statfjord C " 
" 0.08 Åsgård B " 
" 0.01 Grane " 
" 0.15 Oseberg C " 
" 0.03 Heidrun " 
" 0.04 Snorre A " 
" 0.02 Gullfaks B " 
" 0.10 Statfjord C " 
" 0.02 Oseberg C " 
AVERAGE 0.21     
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Table 2. 
Compound 
(group) 
Concentration 
(mg/mL) 
Locality Refrence 
BaP 0.20 Brage Utvik, 1999 
" 0.10 Oseberg C " 
4/5 ring PAH 0.003 Statfjord A Neff et al., 2006 
" 0.004 Statfjord B " 
" 0.001 Statfjord C " 
" 0.001 Gullfaks A " 
" 0.002 Gullfaks B " 
" 0.001 Gullfaks C " 
" 0.002 Veslefrikk " 
" 0.000 Troll A " 
" 0.005 Troll B " 
" 0.005 Snorre TLP " 
" 0.006 Oseberg C " 
" 0.003 Oseberg FS " 
" 0.006 Brage " 
" 0.001 Ekofisk 2/4 K " 
" 0.001 Ekofisk 2/4 J " 
" 0.001 Eldfisk 2/7 B " 
" 0.001 Eldfisk 2/7 A " 
" 0.000 Tor " 
" 0.000 Valhall " 
" 0.005 Ula " 
" 0.001 Gyda " 
AVERAGE 0.015     
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APPENDIX 5. THE PLS MODELL 
 
Tabulated values for the generated models as insignificant terms are excluded sequentially 
from the model.  
 
Terms included in the model R2 
Adjusted 
R2  
Q2 LVs 
All interaction terms 0.91 0.89 0.88 2 
All interaction terms -Car×BaP 0.91 0.89 0.88 2 
All interaction terms -Car×BaP and -
DMP×Bap 
0.91 0.89 0.88 2 
R
2
 = explained variance  
Adjusted R
2
 = R
2 
adjusted for number of explanatory terms 
Q
2
 = predicted variance  
LVs = number of latent variables  
 
 
 
 
 
 
 
 
 
Normal probability plot of the residuals for the utilized PLS model with no non-significant 
terms and parallel 15 and 49 excluded.  
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ANOVA plot compares standard deviation of the regression with standard deviation of the 
residuals, which represent noise present in observations. Good models should have standard 
deviations of regression (SD-regression) much larger than standard deviation of the residuals 
multiplied with its upper confidence level (RSD×sqrt(Fcrit). The model used was significant at 
a 5% confidence level. 
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APPENDIX 6. GEL ELECTROPHORESIS 
 
Relative front (Rf), median molecular length (MML), length of DNA fragments (Ln) and 
relative number of strand breaks per kilo base DNA (RNSB/kb) in PLHC after exposure to 
ternary mixtures of produced water relevant compounds. Exposure and lane (Exp./lane) are 
marked to the left in the table, L= DNA ladder, D= DMSO control, 7,9 and 14 = mixtures 
tested. Calculated values for first and second replicate are presented in Table 1 and 2, 
repectively, raw data are illustrated below 
 
Table 1. 
Tuesday 08.03.10 
Exp./ 
lane 
Rf MML Ln 
Average 
Ln 
RNSB/kb 
Average 
RNSB/kb 
Std. dev. 
L  1 0.620             
D 
2 0.417 55640 33384.0 
 
    
 3 0.414 57179 34307.4 33494.4       
7 
4 0.426 52072 31243.2 
 
2.2E-06   
 5 0.429 49910 29946.0 
 
3.5E-06   
 6 0.417 55484 33290.4   1.8E-07 2.0E-06 1.7E-06 
9 
7 0.420 53923 32353.8 
 
1.1E-06   
 8 0.418 55016 33009.6 
 
4.4E-07   
 9 0.423 52853 31711.8   1.7E-06 1.1E-06 6.2E-07 
14 
10 0.424 52072 31243.2 
 
2.2E-06   
 11 0.414 56867 34120.2 
 
-5.5E-07   
 12 0.423 52853 31711.8   1.7E-06 1.1E-06 1.4E-06 
D 
13 0.416 56554 33932.4       
 14 0.421 53923 32353.8         
L  15 0.544             
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Table 2. 
Saturday 19.03.10 
Exp./ 
lane 
Rf MML Ln 
Average 
LN 
RNSB/kb 
Average 
RNSB/kb 
Std. dev. 
L 1 0.600 13782 8269.2         
D 
2 0.580 15690 9414.0 
 
    
 
3 0.570 17045 10227.0 9733.5       
7 
4 0.577 16271 9762.6 
 
-3.1E-07   
 
5 0.576 16271 9762.6 
 
-3.1E-07   
 
6 0.569 17045 10227.0   -5.0E-06 -1.9E-06 2.7E-06 
9 
7 0.574 16464 9878.4 
 
-1.5E-06   
 
8 0.573 16077 9646.2 
 
9.3E-07   
 
9 0.573 17045 10227.0   -5.0E-06 -1.8E-06 3.0E-06 
14 
10 0.575 16658 9994.8 
 
-2.7E-06   
 
11 0.578 16464 9878.4 
 
-1.5E-06   
 
12 0.579 15884 9530.4   2.2E-06 -6.7E-07 2.5E-06 
D 
13 0.583 15884 9530.4 
 
    
 
14 0.579 16271 9762.6         
L 15 0.599 13587 8152.2         
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